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ABSTRACT 
Gastroschisis is a rare congenital malformation where loops of bowel are protruding 
from the abdominal wall of an infant. The prevalence of gastroschisis has been increasing over 
the past 20 years, particularly in younger women. However, as the number of studies on 
gastroschisis increases each year, it continues to remain unclear why the prevalence is 
increasing and why it disproportionately affects younger mothers. Previous research has 
suggested that environmental or infectious factors may be involved in the pathogenesis of 
gastroschisis. This dissertation aims to explore the possibility of these two factors in relation to 
gastroschisis. 
In study 1, clusters of gastroschisis were identified in space or the combination of space 
and time. Cases and controls came from the National Birth Defects Study (NBDPS) or for some 
study centers from the birth defects surveillance systems. Generalized additive models were 
used to create a continuous map surface of odds ratios (OR) by smoothing over latitude and 
longitude. Data from the NBDPS were used for the Arkansas, California, and Utah study centers 
and the highest adjusted ORs detected were 2.0, 1.3, and 2.4, respectively. In Massachusetts 
and Texas, where surveillance data were used, the highest adjusted ORs observed were 2.4 and 
1.3, respectively, with only the latter state achieving statistical significance. Texas had sufficient 
data to assess the combination of space and time, which identified an increased risk (OR=2.9) in 
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the center of Texas in 2003. The results of this study suggest that clusters of gastroschisis may 
exist and further exploration of environmental or behavioral factors are warranted. 
In study 2, previously observed risk factors were evaluated to assess if they vary in their 
association with gastroschisis cases that do or do not occur in temporal clusters using data from 
the NBDPS. Once temporal clusters were identified within each study site, sociodemographic 
factors, illnesses, and behavioral factors were compared between clustered and non-clustered 
cases; the data were also stratified by maternal age. For illnesses and behavioral factors, site-
adjusted ORs were close to 1.0. Adjusted ORs were increased among older mothers but not 
younger mothers: alcohol use (young: 1.4 [95%CI : 0 .9, 2.1]; older: 3.0 [95%CI : 1.0, 8.8]L obesity 
(young: 0.5 [95%CI : 0.1, 1.8]; older: 4.4 [95%CI : 0.4, 45.0]), exposures to heat sources (young: 
1.1 [95%CI : 0.7, 1.9]; older: 1.9 [95%CI: 0.6, 6.4]), non-steroidal anti-inflammatory drug use 
(young: 1.2 [95%CI : 0.7, 2.0]; older: 2.0 [95%CI: 0.7, 5.9]), and respiratory illnesses (young: 1.1 
[95%CI: 0.6, 2.0]; older: 2.1 [95%CI: 0.7, 6.2]). The results of this study raise questions around 
changes in immune response with increasing maternal age. 
In study 3, the association between genitourinary infections (GUI) and gastroschisis was 
examined using data collected in the Boston University Slone Epidemiology Birth Defects Study. 
Women who reported having any GUI had an elevated risk (adjusted OR: 1.8; 95%CI : 1.3, 2.4) 
and the highest risk was among women who reported a urinary tract infection (UTI) only 
(adjusted OR: 2.3; 95%CI: 1.5, 3.5). When we considered the joint effect of UTis and young 
maternal age, a synergistic effect was observed. The results of this study add further evidence 
that UTis may increase the risk of gastroschisis. 
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1 Introduction 
Gastroschisis is a rare congenital malformation where loops of bowel are protruding 
from the abdominal wall of an infant.1 The recurrence risk of gastroschisis in siblings is small and 
concordance is low in monozygotic twins suggesting that genetics does not play a large role in 
the etiology of gastroschisis.2-4 In addition, gastroschisis often occurs in the absence of other 
congenital anomalies and is rarely associated with chromosomal anomalies or syndromes 
further suggesting that environmental or infection factors are involved.3' 5 
The prevalence of gastroschisis has increased 10 to 20-fold worldwide over the past 15 
years, leading some to call it a pandemic.6 The prevalence of gastroschisis in the US is estimated 
to be 1 per 2,700/ however, when this is stratified by maternal age the prevalence changes to 1 
per 800 in mothers <20 years old, 1 per 1900 in 20-24 year olds, 1 per 4900 in 25-29 year olds, 
and 1 per 17,600 in>= 30 year olds.8• 9 
Young maternal age has consistently been found to be associated with gastroschisis.3• 10 
It has been hypothesized that the strong association between young maternal age and 
gastroschisis may be a result of younger mothers partaking in or more frequently being in 
contact with dangerous exposures, such as cigarette smoking and sexually transmitted 
diseases.8• 11 While some of these risk factors have been associated with gastroschisis, none have 
proven to explain the increasing prevalence in younger mothers. Studies examining 
race/ethnicity as a risk factor and socioeconomic status have been inconclusive. 5' 7' 10' 12• 13 Both 
therapeutic11• 13-17 and non-therapeutic drug10' 14' 15' 17' 18 exposures have been found to be risk 
factors for gastroschisis. 
1 
As the number of studies on gastroschisis increases each year/9 it continues to remain 
unclear why the prevalence is increasing and why it disproportionately affects younger mothers. 
The goal of this dissertation is to further our understanding of gastroschisis and its underlying 
causes. The first study uses a rigorous and systematic method to quantify if gastroschisis occurs 
in clusters of space, time, or space and time. The second study assesses risk factors for 
gastroschisis cases that do and do not occur in clusters. The third study examines the association 
between genitourinary infections and gastroschisis. The first two studies use data from the 
National Birth Defects Study, while the latter study uses data from the Boston University Slone 
Epidemiology Center Birth Defects Study. Both studies are on-going multi-site case-control 
studies. 
The following chapters are presented in the format of a manuscript appropriate for 
submission to a peer-reviewed journal. Each section contains its own specific introduction, 
methods, results, and discussion sections. 
2 
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2 SPATIO-TEMPORAL CLUSTERING OF GASTROSCHISIS 
2.1 ABSTRACT 
Previous research has suggested that gastroschisis cases can occur in clusters. The objective of 
this study was to identify clusters of gastroschisis in space or the combination of space and time. 
For three of the study sites, cases and controls from the National Birth Defects Prevention Study 
(NBDPS) were used (Arkansas, California, and Utah). For Massachusetts and Texas, cases were 
identified using the birth defects registries and a random sample of live-births was selected as 
controls. Generalized additive models were used to create a continuous map surface of odds 
ratios (OR) by smoothing over latitude and longitude. Permutation tests were used to assess the 
significance of location and identify locations with statistically significant increased or decreased 
ORs. In Arkansas, adjusted ORs in the southwest corner were 2.0 and the global deviance was 
not statistically significant (p-value: 0.41) . Adjusted ORs for California indicated areas of 
increased risk with ORs 1.3 (p-value: 0.34) . In Utah, the adjusted ORs were elevated (OR: 2.4) in 
the south-eastern corner of the study area (p-value: 0.34). After adjustment, the highest ORs in 
Massachusetts were 2.4 (p-value: 0.07). In Texas, two statistically significant areas of increased 
risk (0Rs=1.3) were identified (p-value <0.001) after adjustment. Texas had sufficient data to 
assess the combination of space and time, which identified an increased risk (OR=2.9) in the 
center of Texas in 2003. Exploration of possible artifactual, environmental, or behavioral factors 
in these areas may further our understanding of the etiology of gastroschisis. 
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2.2 INTRODUCTION 
Historically studies on disease clusters have focused on explaining an unusually high 
aggregation of cases after they have occurred. Although sometimes these traditional cluster 
studies have been productive,1' 2 typically they are problematic as the criteria for case 
ascertainment can be questionable.3 In addition, the population under study is often defined 
around the cluster after it has been brought to attention that there's a higher rate of disease in 
the area. Therefore it can be difficult to identify a population base from which to assess rates of 
disease.3 Adding to the difficulty of analysis is that there are often small numbers, limited data 
collection, and vague case definitions. 
The problematic issues surrounding cluster investigations can be overcome by the use of 
standardized and comprehensive data collection, as well as rigorous definitions of disease and 
the population base. Previous research has found that gastroschisis clusters can occur in either 
space4-7 or time;4' 8"10 however, only a few studies to date have used a more systematic method 
for assessing clustering of gastroschisis. One study was from a case-control study on 
gastroschisis that used interview data.9 They employed an arbitrary definition of a spatia-
temporal cluster (defined as at least 3 cases within a 30-day period with in one study site) and 
found that 35% of cases occurred in a 'cluster' . Comparing cases that occurred in a cluster to 
those that did not, the authors found that clustered cases had higher odds of having a fever 
versus non-clustered cases. Because this study was not population based, systematic 
identification of clusters was not possible. Another study using data from the Metropolitan 
Atlanta Congenital Defects Program found a temporal cluster in 1988, with 3 times more cases 
than expected.10 In response, a case-control study was conducted to further assess if cocaine 
use could account for the cluster. However, the study was limited by small numbers (15 cases) 
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and did not report other risk factors besides cocaine use. The third study to examine clustering 
of gastroschisis used the North Carolina Birth Defect Registry and a sample of controls from 
birth certificates in the state.7 This study used the most rigorous method of any study to date 
utilizing cases from the entire state and individual level data to control for confounding. They 
identified one spatial cluster in the rural southern Piedmont area. No study to date has formally 
assessed the interaction of space and time for clustering of gastroschisis using population-based 
data. 
The objective of this study is to use rigorous systematic methods to identify clusters of 
gastroschisis in space or the combination of space and time using data from a large population 
based case-control study and birth defect registries. 
2.3 METHODS 
Study data 
For three of the study sites data from the National Birth Defects Prevention Study 
(NBDPS) were used and for two of the study sites data were obtained from Birth Defects 
Registries. In the following sections the NBDPS data is presented first, followed by the registry 
data. 
The NBDPS is an ongoing multi-site population based case-control study. The goal of the 
study is to identify environmental and genetic risk factors for birth defects. Over 35 structural 
birth defects were ascertained in the study, including gastroschisis. The study included 10 study 
centers; however, for the present analysis only data from Arkansas, California, and Utah were 
used due to difficulties in obtaining geocoded data from the other centers. Cases were 
ascertained from the birth defect surveillance systems and prenatally diagnosed and electively 
7 
terminated cases were included as well. Live-born infants with no major structural 
malformations were selected as controls from birth certificates (Arkansas [2000-2003] and Utah) 
and birth hospitals (Arkansas [1997-1999], California) .11· 13 
Mothers of case and control infants were contacted and interviewed within 6 weeks to 
two years after the estimated due date (EDD) to ascertain demographic data and exposures 
during pregnancy, including illness history, medication use, occupational history, and residential 
history from 3 months before pregnancy until birth. Participation rates for the interview were 
69% for all case mothers, 64% for gastroschisis case mothers and 66% for control mothers. 
Clinical geneticists reviewed the medical records on all cases to ensure they met the case 
definition for inclusion in the study. 
Massachusetts and Texas are part of the NBDPS and these two centers allowed for 
access to their birth defects surveillance data to make the present analysis more complete. The 
surveillance data included non-interviewed cases and those cases residing outside the NBDPS 
catchment area. Cases of gastroschisis came from the birth defects registries and controls were 
randomly selected from the birth certificates. All sociodemographic information used in the 
analysis came from the birth certificates for these two centers. 
Geocoded data 
For the sites where NBDPS data were used, the spatial data were obtained from the 
residential history section, which has been geocoded by the Agency for Toxic Substances and 
Disease Registry. Since multiple residences could be reported in the interview, the residence at 
the mid-point of the first trimester was used for this analysis. When reporting addresses, 
mothers were asked what month and year they started residing at an address and when they 
stopped. These dates were recorded and used to determine which residence a mother lived at 
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in her first trimester. Since only the month and year were specified for the start and stop dates, 
we arbitrarily assigned the first of the month. If the start or stop month was missing, but the 
year was available, two assumptions were made in an attempt to fill in the missing month. First, 
to fill in a missing start month, the year when the mother started residing at the address was 
compared to the year of the mother's first trimester. If the start year for the residential address 
occurred in the year prior to her first trimester, then the month of December was assigned to 
the missing start month. By assigning December to the missing month we were conservatively 
assuming a mother only lived at that address for one month out of the year. To calculate a 
missing stop month, the year a mother stopped living at an address was compared to the year of 
the mother's first trimester. If the year when the mother stopped living at that address occurred 
after the year of her first trimester of pregnancy, then the month of January was assigned to the 
missing stop month. 
For centers where registry data were used, the birth address reported on the birth 
certificate was used and served as a proxy for the address during pregnancy. An attempt was 
made to geocode addresses with missing geocodes using ArcGIS14 and Google maps. Mothers 
with missing geocodes or addresses that could not be geocoded (e.g. post office boxes or 
military bases) were excluded from the analysis. 
Spatial analysis 
Generalized additive models (GAMs) were used to examine spatial and spatia-temporal 
clustering. 15' 16 The GAM model used was: Logit [p(x)] =a+ y'z + S(xl, x2). The left hand side of 
the equation is the log of the disease odds, a is the intercept, and z is a vector of the covariates. 
The last term is the non-parametric smoothing function, without which the model simplifies to 
an ordinary logistic regression model. A bivariate smooth function {S{xl, x2)) was used for the 
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spatial analysis where xl and x2 were the longitude and latitude of the maternal residence. A 
loess smoother was used for the smoothing term because it adapts to changes in data density 
and weights points nearby more heavily than those further away. The span size determined the 
amount of data the smoother would use in the smoothing process. For example, a span size of 
0.2 meant that 20% of the data around the location would be used in the smoothing process. In 
a large metropolitan area, 20% of the data may correspond to a smaller geographic area than in 
a rural area. To determine the optimal span size for the model, a series of sizes were tested and 
the value that minimized the Akaike's Information Criterion or AIC was chosen as the final span 
size. 
For the spatial analysis, a rectangular grid was overlaid on the study area and points 
outside the area were removed; in addition, the grid was clipped to exclude lakes, mountains or 
other areas with sparse populations. Using the spatial model, the log odds were predicted at 
each grid point. For the adjustment, covariates were added to the model and the reference 
values for covariates were used to predict the adjusted log odds. To convert the log odds to 
odds ratios {ORs), the log odds at each point in the grid was divided by the log odds of the GAM 
model without the smoothing term. Omitting the smoothing term from the model results in 
calculating the odds of disease over the entire study area; therefore when converting the grid 
points from log odds to ORs, the reference group becomes the entire study area. All modeling 
was performed in R17 and the results ofthe analysis were exported into ArcGIS/ 4 where the 
grids were visualized over the study area with variations in the magnitude of ORs represented 
by various colors. The scale of ORs, as they are depicted by colors, was fixed across the crude 
and adjusted maps within each study center even though the range of ORs varied over the 
maps. In addition, the minimum and maximum values varied across study centers but may be 
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depicted by the same color on the maps. For example, the map for one study center may have 
red represent a maximum OR of 1.3, while for another study center the same shade of red may 
represent 2.4; therefore while the crude and adjusted maps are on the same color scale and can 
be compared within each center, a color comparison across centers cannot be made since the 
color scales are different. 
For centers that had sufficient data, the combination of space and time were assessed. 
To examine space and time, the data were partitioned into one year time spans, with a 6 month 
overlap between each time span, and a series of maps were created for each time span. The 
maps were assembled into movie format, resulting in the smoothing of both space and calendar 
time. 
A global test was conducted to assess if location was significant in the study area (i.e. if a 
map had any areas with significantly increased or decreased ORs). The null hypothesis that case 
status was not dependent on location was tested by comparing the deviance from the model 
with the smoothing term to the model without the smoothing term. The smoothing term is a 
measure of location and therefore the comparison with and without serves to test the 
significance of location. Once the deviance statistic was calculated, it was compared to a 
distribution of deviance statistics generated under the null hypothesis. To obtain this 
distribution, the data were permutated by randomly re-assigning a new residential location to 
each participant, under the null hypothesis that case status was not associated with location . 
The models were re-run with the permuted data and the deviance statistic was calculated. 
These steps were repeated 999 times in order to create a distribution of the statistic under the 
null hypothesis. The deviance statistic from the main analysis was compared to the distribution 
and a p-value less than 0.05 was determined to be a statistically significant association. 
11 
If the global test indicated that location was important, then the next step was to 
determine where areas of significantly increased or decreased odds were located. The local test 
examined the pointwise departure from the null hypothesis that the map had no hot or cold 
spots. To conduct this test, the data were permutated by randomly re-assigning participants a 
new residential location under the assumption that case status is not associated with location. 
The models were re-run and at each point on the grid the log odds was calculated . These steps 
were repeated 999 times in order to create a distribution of log odds at each point on the grid. 
The results from the main analysis were compared to the distribution to assess how likely it was 
that the log odds from our results were due to chance. All grid points that fell into the upper or 
lower 2.5% of the distribution were considered statistically significant hot or cold spots. 
For the NBDPS data, the following covariates from the interview were assessed for 
inclusion in the final model: maternal age (reference: ~25 years of age), maternal race/ethnicity 
(reference: Non-Hispanic White), maternal education (reference: >12 years), income( reference : 
~$50,000), body mass index(reference: 18.5-24.9), first trimester alcohol use (reference: no 
use), first trimester smoking (reference: non-smoker), illicit drug use anytime in pregnancy 
(reference: no use), gestational diabetes (reference: no), nativity (reference: U.S. born), and 
total number of residences during pregnancy (reference: 1). For the registry data the following 
covariates were assessed: insurance status (MA only, reference: private insurance), maternal 
age (reference: ~25 years of age), race/ethnicity (reference: Non-Hispanic White), years of 
education (reference: >12 years), and cigarette smoking (reference: non-smoker). To determine 
the final list of risk factors to adjust for in the models, risk factors were added one at a time to 
the model and adjusted maps were generated. The surfaces of the maps were visually examined 
and those variables that changed the surface were included for adjustment. The span size was 
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also taken into account and if the span size changed, the variable was considered for 
adjustment. Based on these methods, all final maps were adjusted for maternal age and 
race/ethnicity. 
2.4 RESULTS 
NBDPS data 
A total of 371 case and 2,359 control mothers had geocoded in-state addresses and 
were included in the spatial analysis of NBDPS data. Compared to case mothers, control mothers 
were more likely to be older, more educated, obese, multiparous, and less likely to smoke or use 
illicit drugs in pregnancy (Table 2.1). When the data were stratified by maternal age, younger 
control mothers (<25 years of age) were more likely to report being non-Hispanic Black race, 
obese, multiparous, and to have lived at fewer residences during pregnancy compared to 
younger case mothers (Table 2.2). The individual results for each study center are presented 
below. 
NBDPS data: Arkansas 
A total of 200 mothers were excluded from the analysis due to not reporting an address 
at the mid-point of the first trimester (27 cases and 143 controls) or residing out of state (7 
cases and 23 controls), resulting in a total of 100 cases and 905 controls used in the spatial 
analysis. The cases and controls represented births from January 1998 through December 2007. 
In Arkansas the NBDPS catchment area encompasses the entire state and the spatial distribution 
of mothers' residences can be seen in Figure 2.1. To preserve confidentiality in the point data 
maps the exact locations were altered but in all the analyses the exact locations were used. 
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The spatial analysis revealed elevated crude ORs in the southwest corner of the state, 
with the highest ORs equaling 2.3 (p-value: 0.439; span size: 0.95) (Figure 2.2). After adjustment 
for maternal age and race/ethnicity, ORs for a non-Hispanic white woman ~25 years of age in 
the southwest corner were attenuated to 2.0 and the global deviance remained non-statistically 
significant (p-value: 0.583; span size: 0.95) (Figure 2.3). 
NBDPS data: California 
In California, 158 mothers were excluded from the analysis due to not reporting an address 
at the mid-point of the first trimester (20 cases and 112 controls) or residing out of state (2 
cases and 24 controls). A total of 193 cases and 892 controls were used in the spatial analysis 
and included births from October 1997 through December 2007. The NBDPS catchment area in 
California is located in the central valley and is comprised of Fresno, Kern, Kings, Madera, 
Merced, San Joaquin, Stanislaus and Tulare counties. Due to the geography of this area, the 
prediction grid was clipped to exclude the mountains in the east and the sparse populations in 
the west. The distribution of mothers' residences can be seen in Figure 2.4 and the 8 counties 
included in the catchment area are highlighted in pink. To determine the optimal span size for 
the models, only data from the 8 counties were used. Once the optimal span size was 
determined, all the data were used in the final models (i.e. mothers that resided outside the 
catchment area in the first trimester were included in the modeling). 
Figure 2.5 shows the results of the crude spatial analysis, which revealed a slight 
elevation in risk along the eastern and western borders ofthe study area, with the maximum 
ORs at 1.3 (p-value: 0.274; span-size: 0.95). After adjustment for maternal age and 
race/ethnicity the maximum ORs did not change (OR: 1.3) and the pattern of risk did not change 
substantially (p-value: 0.343; span-size: 0.85) (Figure 2.6). 
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NBDPS data: Utah 
Utah joined the NBDPS in 2003, therefore data for Utah only included births from 
January 2003 through December 2007. In this center, 64 mothers were excluded from the 
analysis due to not reporting an address at the mid-point of the first trimester {6 cases and 35 
controls) or residing out of state (2 cases and 21 controls). A total of 78 cases and 562 controls 
were used in the spatial analysis. 
The NBDPS catchment area in Utah included the entire state; however due to the sparse 
population in southern Utah, the spatial analysis was restricted to the geograpahic area around 
Salt Lake City. Most of the population in the Salt Lake area live along the 1-15 corridor that runs 
north-south (Figure 2.7). The grid was clipped to exclude the lakes around Salt Lake City as well 
as the mountains in the east. Removing these points ensured that the models were not 
prediciting ORs for locations where no one resided. To determine the optimal span size to use in 
the models, only data from the 5 counties around Salt Lake City were utilized as this is the area 
where the grid would be predicting. When running the final models, all the data in the state 
were used to predict the ORs at each grid point. Prior to adjustment the maximum OR was 2.5 
(p-value: 0.613; span-size: 0.30) and after adjustment for maternal age and race/ethnicity there 
was a slight decrease in the maximum OR for a non-Hispanic white woman ~25 years of age 
(maximum OR: 2.4; p-value: 0.342; span-size: 0.45) (Figures 2.8-2.9). 
Registry data: Massachusetts 
In Massachusetts, data were obtained from the Center for Birth Defects Research and 
Prevention at the Massachusetts Department of Public Health for the years 2000 through 2007. 
After restricting to only in-state births, 156 cases were identified from the MA birth defects 
monitoring program and 9,000 controls were randomly selected from the birth certificate. One 
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case and 81 controls were excluded due to no available geocoded address, resulting in a total of 
155 cases and 8,919 controls. Compared to case mothers, control mothers were more likely to 
be older, more educated, privately insured, and less likely to smoke in pregnancy (Table 2.3). 
Among younger mothers, control mothers were more likely to be of other races and have 
private insurance; while for older mothers, control mothers were more likely to report being 
non-Hispanic White, have more years of education, be non-smokers, and have private insurance 
(Table 2.4). 
The spatial distribution of case and control mothers can be seen in Figure 2.10. The 
crude map of MA showed elevated risks in the northern area of the state, with the highest ORs 
at 2.4 (p-value: 0.001; span size: 0.65) . The local test identified areas of statistically significant 
increased and decreased risks that are denoted by the black bands in Figure 2.11. Once the map 
was adjusted for maternal age and race/ethnicity, the ORs in the north-central area were 
attenuated and were 1.8 (Figure 2.12). After adjustment the risks for the eastern portion of 
Cape Cod were elevated for a non-Hispanic white woman ~25 years of age (OR=2.4); though it 
should be noted that the eastern area only contained one case and location overall was no 
longer statistically significant (p-value: 0.065; span size: 0.85) . 
Registry data: Texas 
In Texas, data were obtained from the Texas Department of State Health Services for 
the years 1999 through 2008. Cases of gastroschisis came from the Texas Birth Defects Registry 
and controls were randomly selected from the birth certificates. A total of 1,756 cases were 
identified and 10,000 controls were randomly sampled from the birth certificates. Of those, 
1,687 cases and 9, 706 controls had valid geocoded addresses and were included in the spatial 
analysis. Compared to case mothers, control mothers were more likely to be older, more 
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educated, and less likely to smoke in pregnancy (Table 2.5). Among older mothers, control 
mothers were more likely to have more years of education and be non-smokers compared to 
case mothers (Table 2.6). 
Figure 2.13 shows the spatial distribution of case and control mothers in Texas. The 
crude map revealed elevated ORs (maximum OR: 1.6) in the center of the state and along the 
coast near Corpus Christi (p-value < 0.001; span-size: 0.30) (Figure 2.14). These regions were 
found to be statistically significant as depicted by the significance bands. After adjustment for 
maternal age and race/ethnicity the maximum ORs for a non-Hispanic white woman ~25 years 
of age were attenuated to 1.3 (Figure 2.15) . Even with the attenuation in risk, the p-value 
remained statistically significant (p-value < 0.001; span size: 0.40) and the significance bands 
identified the central and Corpus Christi region as areas of statistically significant increased risk. 
Given the large number of cases in Texas we were able to assess the combination of 
space and time. First, the data were partitioned into calendar years (January 1st- December 
31st) and maps were generated for each year. Then data were then partitioned into overlapping 
years (July 1st- June 30th) and maps were created for each year of data. To create a movie 
representing the combination of space and time, the maps for calendar year were placed in 
succession and the July through June maps were placed between the calendar year maps to 
smooth over time. Figure 2.16 shows the calendar year maps (January- December) for each 
year of the data. In 1999 (p-value: 0.093; span size: 0.30), 2003 (p-value: 0.001; span size: 0.75), 
and 2004 (p-value: 0.048; span size: 0.45) there appeared to be elevated risks in the western, 
central, and northern parts of Texas, though only the last two years had statistically significant 
p-values. 
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2.5 DISCUSSION 
Elevated risks were identified in all the study centers. In the study centers that used 
NBDPS data the maximum adjusted ORs ranged from 1.3 to 2.4 depending on the study center 
(AR: highest OR= 2.0; CA: highest OR= 1.3; UT: highest OR= 2.4), though in all three centers the 
variations in ORs within each centers were not found to be statistically significant. For 
Massachusetts and Texas, which used registry data, the highest adjusted ORs were 2.4 and 1.3, 
respectively, with the latter study site being the only one to reach statistical significance after 
adjusting for confounders. Additionally, in Texas significant areas of increased risk were 
identified in 2003 and 2004. In all the study centers only maternal age appeared to alter the ORs 
and span sizes. Adjusting for other covariates made little difference in the maps, which is 
consistent with other studies of gastroschisis where maternal age is often the strongest 
confounder. In the maps, maternal race/ethnicity was also included as a covariate as it has been 
previously associated with gastroschisis and the spatial distributions of mothers of various 
races/ethnicities may vary. 18-20 
There have been numerous critiques of using statistical tests to interpret data due to 
misinterpretation of significance tests, the arbitrariness of cut-offs, as well as the fact that many 
readers will equate statistical significance with a real or valid association. 21-24 While in this study 
we choose to use p-values, we did so to assist in determining when to interpret spatial 
variability and to prevent over interpretation ofthe data. In our study some areas had sparse 
data which could have led to spurious results. For example, in Massachusetts we saw the 
adjusted ORson the eastern portion of Cape Cod were elevated (OR: 2.4; p-value: 0.065)) but 
when we looked at the underlying data we saw that only 7 cases resided on Cape Cod and of 
those, only one lived in the eastern half where the adjusted ORs were elevated. We therefore 
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were using the non-significant p-value to suggest a more cautious interpretation of these 
results. It is also possible that some of the elevated areas may be evidence of a true increased 
risk and that the numbers were too small to reach statistical significance. To assess the 
possibility of this, we examined various thresholds of statistical significance as possible cut-offs. 
However, with the exception of Massachusetts, all the maps with non-significant p-values had p-
values greater than 0.3 suggesting that many of the estimates were fairly unstable. Another 
approach we could have used was to calculate confidence intervals around the estimates, 
however they would have been difficult to display visually. 
We cannot rule out the possibility that some of the spatial variation detected was due 
to residual confounding or spatial confounding. Spatial confounding occurs when there is an 
uneven spatial distribution of an uncontrolled risk factor. For example, if one neighborhood has 
a high density of cigarette smokers, then a cluster of lung cancer may be observed in that 
neighborhood; however, no cluster would have been detected if smoking had been controlled 
for. To reduce the possibility of confounding, we assessed a variety of individual level 
sociodemographic and behavioral factors as possible covariates in the models. 
In some of the states, ORs were elevated around the edges of the grid and could be the 
result of edge effects. Edge effects often occur with cluster detection methods, including GAMs, 
and arise from a lack of data across the border of the study area. The absence of data at the 
edge may lead to inaccurate estimations near the boundaries of a study area. There may be less 
concern of edge effects for states where the grids were clipped (CA and UT only), since data 
outside the modeling area were used. While the possibility of this effect cannot be ruled out, a 
previous study using simulated data found that no edge effects were apparent when using 
GAMs, even when an edge was self-imposed on the data by cutting the spatial area in half.16 
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There are many advantages of using GAMs to examine spatial variability and identify 
areas of increased or decreased risk. The first was that it allowed us to use individual level data 
so that we did not have to aggregate cases to artificial boundaries (e.g., county or census tract) . 
In addition, we were also able to simultaneously adjust for many individual level covariates. 
Given that many of our study centers included both rural and urban areas, another advantage 
was the use ofthe smoothing term that adapted to changes in population density. 
One limitation of NBDPS was the possibility of differential participation by cases and 
controls. In NBDPS the participation rate for mothers of gastroschisis cases is a bit lower than 
cases overall (64% versus 69%, respectively), which could be due to case mothers being younger 
and it has been shown that younger mothers are less likely to participate. 25' 26 Another limitation 
was the potential for non-differential reporting bias. Since mothers could be interviewed up 
until 2 years after the EDD, it is possible that some mothers may not have correctly remembered 
their residential history, behaviors or exposures during pregnancy. The use of a standardized 
questionnaire as well as trained interviewers reduced the likelihood of reporting bias, but we 
cannot rule out the possibility of this bias. Another limitation was that the spatial distribution of 
cases and controls could have been affected by ascertainment methods and how mothers' 
sought obstetric care within each study area. For example, in Arkansas controls were selected 
from all liveborn infants delivered in any Arkansas hospital, while cases came from all in-state 
births as well as births at 2 hospitals in neighboring Texas where agreements were in place to 
share information on Arkansas residents. But, as a previous paper found, there was an 
underascertainment of cases along the northeastern border of the state. The authors suggested 
this may be due to mothers with high risk pregnancies (such as those with a birth defect) 
seeking care across the border in Memphis, Tennessee. Since no agreements were in place with 
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Tennessee, these deliveries to Arkansas mothers were missed. Thus underascertainment of 
cases along the northeastern border may explain the decreased risks we observed around that 
area. Another limitation was that we excluded mothers from the analysis who did not have 
geocoded addresses or mothers that resided out-of-state. The proportions of women that were 
excluded were similar between cases and controls (13.5% and 12.3%, respectively, in AR, CA and 
UT combined), suggesting that the exclusion was non-differential. When looking at the 
demographics of the excluded mothers, cases were slightly more likely to be younger and both 
excluded cases and controls were more likely to report a non-white race/ethnicity. 
One of the strengths of using NBDPS data was the availability of the residential history 
data, which allowed us to use the address at the etiologically relevant time period for 
gastroschisis. When using the registry data, we assumed the address at the time of birth was a 
proxy for the address that the mother would have resided at in her first trimester. Previous 
studies have suggested that mobility during pregnancy can range from 12-31%,27-30 but that the 
majority of moves occur intracounty (51%) rather than intercounty (23%).28 The largest estimate 
of mobility during pregnancy (31%) came from a study conducted in Texas that compared 
addresses from the birth certificate to the residential history data from the NBDPS. The authors 
found that mobility rates between cases and controls were similar in each trimester of 
pregnancy/ 0 these findings were confirmed in another study that compared mobility during 
pregnancy among mothers of infants with birth defects and those without.28 These results 
suggest that while use of delivery address as a proxy may be subject to some misclassification, it 
is likely to be non-differential. Given that residential address is considered our exposure in this 
analysis, we would expect that the result of this misclassification would lead to an 
underestimate of the true effect. While there was the opportunity for misclassification of 
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address with the registry data, one of the strengths of using this data was that we were able to 
use all the cases in a state, regardless of whether they had participated in the NBDPS study. In 
determining clusters this could provide a real advantage as we were less likely to miss a cluster 
due to non-participation of mothers. In addition, we were able to include areas of 
Massachusetts and Texas outside the NBDPS catchment area and examine an overall larger 
area. 
The goal of our study was to explore the possibility that gastroschisis might occur in 
clusters and generate possible hypothesis on the etiology of gastroschisis that could direct 
future studies. Our results suggested that gastroschisis may in fact occur in clusters in some 
study centers and that additional exploration of possible artifactual, environmental, or 
behavioral factors in these areas may further our understanding of the etiology of gastroschisis. 
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2.7 TABLES 
Table 2.1: Sociodemographic and behavioral factors for cases and controls in Arkansas, 
California, and Utah, National Birth Defects Prevention Study, 1997-2007. 
Cases Controls 
N % N % 
Total 371 100.0% 2359 100.0% 
Maternal age 
<20 137 36.9% 311 13.2% 
20-24 161 43.4% 690 29.2% 
25-29 54 14.6% 700 29.7% 
30-34 17 4.6% 445 18.9% 
35+ 2 0.5% 213 9.0% 
Education 
<12 years 108 29.1% 471 20.0% 
12 years 152 41.0% 658 27.9% 
>12 years 109 29.4% 1222 51.8% 
Missing 2 0.5% 8 0.3% 
Body mass index 
<18.5 24 6.5% 124 5.3% 
18.5-24.9 261 70.4% 1194 50.6% 
25-29.9 59 15.9% 512 21.7% 
30+ 21 5.7% 425 18.0% 
Missing 6 1.6% 104 4.4% 
Alcohol 
No 252 67.9% 1728 73.3% 
Yes B1-M3 119 32.1% 618 26.2% 
Missing 0 0.0% 13 0.6% 
Maternal race 
NH white 188 50.7% 1386 58.8% 
NH Black 14 3.8% 223 9.5% 
Hispanic 122 32.9% 593 25.1% 
Other 46 12.4% 155 6.6% 
Missing 1 0.3% 2 0.1% 
Nativity 
Born in the US 312 84.1% 1926 81.6% 
Foreign Born 56 15.1% 426 18.1% 
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Missing 3 0.8% 7 0.3% 
Smoking 
No 259 69.8% 1939 82.2% 
Yes B1-P3 112 30.2% 415 17.6% 
Missing 0 0.0% 5 0.2% 
Parity 
0 249 67.1% 892 37.8% 
1 76 20.5% 770 32.6% 
2 33 8.9% 414 17.5% 
3+ 13 3.5% 283 12.0% 
Income 
<$10,000 110 29.6% 486 20.6% 
$10,000-$50,000 194 52.3% 1199 50.8% 
>$50,000 31 8.4% 497 21.1% 
Missing 36 9.7% 177 7.5% 
Drug use from 3 months before pregnancy through the end of pregnancy 
No 312 84.1% 2220 94.1% 
Yes 59 15.9% 139 5.9% 
Pregnancy intention 
No, didn't care, wanted to wait 174 46.9% 793 33.6% 
Yes 125 33.7% 1096 46.5% 
Missing 72 19.4% 470 19.9% 
Gestational diabetes in index pregnancy 
No 368 99.2% 2257 95.7% 
Yes 3 0.8% 99 4.2% 
Missing 0 0.0% 3 0.1% 
Number of residential addresses reported from 3 months before pregnancy 
through the end of pregnancy 
1 167 45.0% 1636 69.4% 
2 144 38.8% 573 24.3% 
3+ 60 16.2% 149 6.3% 
Missing 0 0.0% 1 0.0% 
Average time living at address used in spatial analysis 
Mean 1,009 days 1,367 days 
Median 608 days 914 days 
Min 30 days 30 days 
Max 8,430 days 20,971 days 
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Table 2.2: Sociodemographic and behavioral factors for cases and controls in Arkansas, 
California, and Utah by maternal age, National Birth Defects Prevention Study, 1997-2007. 
< 25 years of age ~ 25 years of age 
Case Control Case Control 
N (%) N (%) N (%) N (%) 
Total 298 (100) 1001 (100) 73 (100) 1358 (100) 
Education 
<12 years 98 (32.9) 298 (29.8) 10 (13.7) 173 (12.7) 
12 years 129 (43.3} 369 (36.9) 23 (31.5) 289 (21.3) 
>12 years 69 (23.2) 330 (33) 40 (54.8) 892 (65.7) 
Missing 2 (0.7) 4 (0.4) 0 (0.0) 4 (0.3} 
BMI 
<18.5 22 (7.4) 77 (7.7) 2 (2.7) 47 (3 .5) 
18.5-24.9 212 (71.1) 523 (52.2) 49 (67.1) 671 (49.4) 
25-29.9 47 (15.8) 197 (19.7) 12 (16.4) 315 (23.2) 
30+ 13 (4.4) 156 (15.6) 8 (11.0) 269 (19.8) 
Missing 4 (1.3) 48 (4.8) 2 (2.7) 56 (4.1) 
Alcohol 
No 206 (69.1) 738 (73.7) 46 (63.0) 990 (72.9) 
Yes Bl-M3 92 (30.9) 259 (25.9) 27 (37.0) 359 (26.4) 
Missing 0 (0.0) 4 (0.4) 0(0.0) 9 (0.7) 
Maternal race 
NH white 148 (49.7} 503 (50.2) 40 (54.8) 883 (65) 
NH Black 12 (4.0) 148 (14.8) 2 (2.7) 75 (5 .5) 
Hispanic 101 (33.9) 295 (29.5) 21 (28.8) 298 (21.9) 
Other 36 (12.1) 55 (5.5) 10 (13.7) 100 (7.4) 
Missing 1 (0.3) 0 (0.0) 0 (0.0) 2 (0.1) 
Smoking 
No 208 (69.8) 762 (76.1) 51 (69.9) 1177 (86.7} 
Yes Bl-P3 90 (30.2) 237 (23.7) 22 (30.1) 178 (13.1) 
Missing 0 (0.0) 2 (0.2) 0 (0.0) 3 (0.2) 
Parity 
0 222 (74.5} 560 (55.9} 27 (37.0) 332 (24.4) 
1 52 (17.4} 314 (31.4) 24 (32.9) 456 (33.6) 
2 20 (6.7} 96 (9.6} 13 (17.8} 318 (23.4} 
3+ 4 (1.3} 31 (3.1) 9 (12.3} 252 (18.6} 
Income 
<$10,000 97 (32.6} 308 (30.8} 13 (17.8) 178 (13.1) 
$10,000-$50,000 154 (51.7) 519 (51.8) 40 (54.8) 680 (50.1) 
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>$50,000 16 (5.4) 52 (5.2) 15 (20.5) 445 (32.8) 
Missing 31 (10.4) 122 (12.2) 5 (6.8) 55 (4.1) 
Nativity 
Born in the USA 255 (85.6) 834 (83.3) 57 (78.1) 1092 (80.4) 
Foreign born 41 (13.8) 164 (16.4) 15 (20.5) 262 (19.3) 
Missing 2 (0.7) 3 (0.3) 1 (1.4) 4 (0.3) 
Drug use from 3 months before pregnancy through the end of pregnancy 
No 252 (84.6) 909 (90.8) 60 (82.2) 1311 (96.5) 
Yes 46 (15.4) 92 (9.2) 13 (17.8) 47 (3.5) 
Pregnancy intention 
No, didn't care, 145 (48.7) 436 (43.6) 29 (39.7) 357 (26.3) 
wanted to wait 
Yes 96 (32.2) 379 (37.9) 29 (39.7) 717 (52.8) 
Missing 57 (19.1) 186 (18.6) 15 (20.5) 284 (20.9) 
Gestational diabetes in index pregnancy 
No 295 (99.0) 970 (96.9) 73 (100.0) 1287 (94.8) 
Yes 3 (1.0) 29 (2.9) 0 (0.0) 70 (5.2) 
Missing 0 (0.0) 2 (0.2) 0 (0.0) 1 (0.1) 
Number of residential addresses reported from 3 months before pregnancy through 
the end of pregnancy 
1 
2 
3 
Missing 
124 (41.6) 
123 (41.3) 
51 (17.1) 
0 (0.0) 
564 (56.3) 
326 (32.6) 
110 (11.0) 
1 (0.1) 
Average time living at address used in spatial analysis 
Mean 1,005 days 1,235 days 
Median 550 days 700 days 
Min 30 days 30 days 
Max 8,430 days 9,374 days 
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43 (58.9) 
21 (28.8) 
9 (12.3) 
0 (0.0) 
1,028 days 
731 days 
31 days 
5,205 days 
1072 (78.9) 
247 (18.2) 
39 (2.9) 
0 (0.0) 
1,466 days 
1,124 days 
31 days 
20,971 days 
Table 2.3: Sociodemographic and behavioral factors for cases and controls, Massachusetts Birth 
Defects Registry, 2000-2007. 
Cases Control 
N % N % 
Total 155 100.0% 8919 100.0% 
Age 
< 20 53 34.2% 566 6.3% 
20-24 58 37.4% 1364 15.3% 
25-29 30 19.4% 2069 23.2% 
30-34 12 7.7% 2858 32.0% 
35+ 2 1.3% 2062 23.1% 
Race 
Non-Hispanic White 87 56.1% 5957 66.8% 
Other Races 68 43.9% 2946 33.0% 
Missing 0 0.0% 16 0.2% 
Education 
<12 years 35 22.6% 963 10.8% 
12 years 91 58.7% 3445 38.6% 
> 12 years 27 17.4% 4511 50.6% 
Missing 2 1.3% 0 0.0% 
Smoking during pregnancy 
Yes 20 12.9% 737 8.3% 
No 134 86.5% 8166 91.6% 
Missing 1 0.6% 16 0.2% 
Insurance 
Private insurance 47 30.3% 6002 67.3% 
Government insurance, 101 65.2% 2662 29.8% 
self-pay, none 
Missing 7 4.5% 255 2.9% 
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Table 2.4: Sociodemographic and behavioral factors for cases and controls by maternal age, 
Massachusetts Birth Defects Registry, 2000-2007. 
< 25 years of age ::!: 25 years of age 
Cases Control Cases Control 
N (%) N (%) N (%) N (%) 
Total 111 (100) 1930 (100) 44 (100) 6989 (100) 
Race 
Non-Hispanic White 58 (52.3) 918 (47.6) 29 (65.9) 5039 (72 .1) 
Other Races 53 (47.7) 1007 (52.2) 15 (34.1) 1939 (27 .7) 
Missing 0 (0.0) 5 (0.3) 0 (0.0) 11 (0.2) 
Education 
<12 years 32 (28.8) 561 (29.1) 3 (6.8) 402 (5.8) 
12 years 69 (62 .2) 1204 (62.4) 22 (50.0) 2241 (32.1) 
> 12 years 9 (8.1) 165 (8.5) 18 (40.9) 4346 (62.2) 
Missing 1 (0.9) 0 (0.0) 1 (2 .3) 0 (0.0) 
Smoking during pregnancy 
Yes 17 (15.3) 305 (15.8) 3 (6.8) 432 (6.2) 
No 94 (84.7) 1621 (84.0) 40 (90.9) 6545 (93.6) 
Missing 0 (0.0) 4 (0.2) 1 (2.3) 12 (0.2) 
Insurance 
Private insurance 23 (20.7) 552 (28.6) 24 (54.5) 5450 (78.0) 
Government insurance, 82 (73.9) 1288 (66.7) 19 (43.2) 1374 (19.7) 
self-pay, none 
Missing 6 (5.4) 90 (4.7) 1 (2.3) 165 (2 .4) 
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Table 2.5: Sociodemographic and behavioral factors for cases and controls, Texas Birth Defects 
Registry, 1999-2008. 
Cases Control 
N % N % 
Total 1687 100.0% 9706 100.0% 
Age 
< 20 727 43.1% 1368 14.1% 
20-24 689 40.8% 2695 27.8% 
25-29 185 11.0% 2560 26.4% 
30-34 so 3.0% 1981 20.4% 
35+ 29 1.7% 1097 11.3% 
Missing 7 0.4% 5 0.1% 
Race 
Non-Hispanic White 606 35.9% 3592 37.0% 
Hispanic 940 55.7% 4565 47.0% 
Other Races 139 8.2% 1534 15.8% 
Missing 2 0.1% 15 0.2% 
Education 
<12 years 731 43.3% 2945 30.3% 
12 years 581 34.4% 2826 29.1% 
~ 12 years 361 21.4% 3839 39.6% 
Missing 14 0.8% 96 1.0% 
Smoking during pregnancy 
Yes 130 7.7% 577 5.9% 
No 1553 92.1% 9076 93.5% 
Missing 4 0.2% 53 0.5% 
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Table 2.6: Sociodemographic and behavioral factors for cases and controls by maternal age, 
Texas Birth Defects Registry, 1999-2008. 
< 25 years of age 2: 25 years of age 
Cases Control Cases Control 
N (%) N (%) N (%) N (%) 
Total 1416 (100) 4063 (100} 264 (100) 5638 (100} 
Race 
Non-Hispanic White 481 (34.0) 1177 (29.0) 125 (47.3) 2414 (42 .8) 
Hispanic 822 (58.1) 2219 (54.6) 114 (43.2) 2343 (41.6} 
Other Races 111 (7 .8) 664 (16.3) 25 (9 .5) 869 (15.4) 
Missing 2 (0.1) 3 (0.1) 0 (0.0) 12 (0.2) 
Education 
<12 years 656 (46.3) 1703 (41.9} 71 (26.9) 1240 (22 .0) 
12 years 506 (35.7) 1515 (37.3) 74 (28.0) 1310 (23 .2) 
> 12 years 243 (17 .2) 804 (19.8} 116 (43.9) 3035 (53 .8} 
Missing 11 (0.8) 41 (1.0) 3 {1.1) 53 (0.9) 
Smoking during pregnancy 
Yes 102 (7.2) 318 (7.8) 28 (10.6) 259 (4.6) 
No 1311 {92.6) 3735 (91.9) 236 (89.4) 5337 (94.7) 
Missing 3 (0.2) 10 (0.2) 0 (0.0) 42 (0.7) 
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2.8 FIGURES 
Figure 2.1 : Distribution of cases and controls in Arkansas, National Birth Defects Prevention 
Study, 1998-2007. 
I 
0 40 Miles 
Locations have been altered to preserve confidentiality. 
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Figure 2.2: Map of crude odds ratios for Arkansas, National Birth Defects Prevention Study, 
1998-2007. 
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Figure 2.3: Map of odds ratios for Arkansas adjusted for maternal age and race/ethnicity, 
National Birth Defects Prevention Study, 1998-2007. 
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Figure 2.4: Distribution of cases and controls in California, National Birth Defects Prevention 
Study, 1997-2007. 
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Locations have been altered to preserve confidentiality. Counties highlighted in pink denote the 
study catchment area. 
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Figure 2.5: Map of crude odds ratios for California, National Birth Defects Prevention Study, 
1997-2007. 
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Figure 2.6: Map of odds ratios for California adjusted for maternal age and race/ethnicity, 
National Birth Defects Prevention Study, 1997-2007. 
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Figure 2.7 : Distribution of cases and controls in Utah, National Birth Defects Prevention Study, 
2003-2007. 
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Figure 2.8: Map of crude odds ratios for Utah, National Birth Defects Prevention Study, 2003-
2007. 
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Figure 2.9: Map of odds ratios for Utah adjusted for maternal age and race/ethnicity, National 
Birth Defects Prevention Study, 2003-2007. 
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Figure 2.10: Distribution of cases and controls in Massachusetts, Massachusetts Birth Defects 
Registry, 2000-2007. 
Locations have been altered to preserve confidentiality. 
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Figure 2.11: Map of crude odds ratios for Massachusetts, Massachusetts Birth Defects Registry, 
2000-2007. 
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Figure 2.12: Map of odds ratios for Massachusetts adjusted for maternal age and race/ethnicity, 
Massachusetts Birth Defects Registry, 2000-2007. 
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Figure 2.13: Distribution of cases and controls in Texas, Texas Birth Defects Registry, 1999-
2008. 
Locations have been altered to preserve confidentiality. 
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Figure 2.14: Map of crude odds ratios for Texas, Texas Birth Defects Registry, 1999-2008. 
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Figure 2.15: Map of odds ratios for Texas adjusted for maternal age and race/ethnicity, Texas 
Birth Defects Registry, 1999-2008. 
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Figure 2.16: Map of age adjusted odds ratios for Texas by birth year, Texas Birth Defects 
Registry, 1999-2008. 
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3 IDENTIFYING RISK FACTORS FOR GASTROSCHISIS USING CASE CLUSTERS 
3.1 ABSTRACT 
Previous research has suggested that gastroschisis can occur in clusters. This study examined 
whether previously observed risk factors vary in their association with gastroschisis cases that 
do or do not occur in clusters. Interviewed and non-interviewed eligible cases from the National 
Birth Defects Prevention Study, a multi-site population-based case-control study, were used in 
the analysis. Based on the center-specific expected number of cases in any 30-day period, a 
150% excess of gastroschisis births within a 30 day period constituted a cluster. The pattern of 
excess occurrences was compared to a second method for assessing clusters that used 
generalized additive models {GAMs) with a univariate smoothing function to represent time 
adjusting for maternal age, education, and race/ethnicity (interviewed cases and controls only). 
Cases were grouped as clustered or non-clustered using the 150% excess method. Using data 
collected by telephone interviews, sociodemographic factors, illnesses, and behavioral factors 
were compared between clustered and non-clustered cases. The strength of association for 
each factor was assessed by estimating odds ratios (ORs) and 95% confidence intervals {Cis) 
using a logistic model for cases overall and stratified by maternal age ('young' <25 and 'older' 
~25) . Compared to 533 non-clustered cases, the 143 clustered cases were proportionally more 
likely to have lower incomes, lived at >1 residence during pregnancy and have used saunas in 
the first trimester of pregnancy. For illnesses and behavioral factors, site-adjusted ORs were 
close to 1.0. Adjusted ORs were increased among older mothers but not younger mothers: 
alcohol use (young: 1.4 [95%CI: 0.9, 2.1]; older: 3.0 [95%CI: 1.0, 8.8]), obesity (young: 0.5 
[95%CI: 0.1, 1.8]; older: 4.4 [95%CI: 0.4, 45.0]), exposures to heat sources (young: 1.1 [95%CI: 
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0.7, 1.9]; older: 1.9 [95%CI: 0.6, 6.4]), non-steroidal anti-inflammatory drug use (young: 1.2 
[95%CI: 0 .7, 2.0]; older: 2.0 [95%CI : 0.7, 5.9]), and respiratory illnesses (young: 1.1 [95%CI: 0 .6, 
2.0]; older: 2.1 [95%CI: 0.7, 6.2]). However, the numbers were small and Cis were wide. The 
results of this study raise questions around aging within the child bearing years and differences 
in clustering patterns. Possible explanations may include a cumulative effect of certain 
exposures across age or biological differences according to age. Additional studies are needed to 
further explore these patterns. 
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3.2 INTRODUCTION 
Young maternal age has consistently been associated with gastroschisis.1' 2 The strong 
association between young maternal age and gastroschisis has been hypothesized to result from 
younger mothers partaking in or more frequently being in contact with dangerous exposures, 
such as cigarette smoking and sexually transmitted diseases {STDs) . As a matter of fact, cigarette 
smoking has been positively associated with gastroschisis.3 Along similar lines, illicit drug use, 
particularly marijuana and cocaine, has also been associated with an increased risk of 
gastroschisis. 2' 4-7 Other possible risk factors that have been identified for gastroschisis include 
Hispanic ethnicity, change in paternity, lower socioeconomic status, urinary tract infections 
(UTis) in combination with STDs, aspirin use, and decongestant use.2' 4' 6-14 While some of these 
risk factors have been associated with gastroschisis, none have proven to explain the increasing 
prevalence in younger mothers and the strong inverse age association remains in multivariable 
models that adjust for them. 
One possible clue in understanding the etiology of gastroschisis, is that it has been 
observed to occur in clusters. 15-18 Previous research has found that gastroschisis clusters can 
occur in either space and/ or time, 1' 15' 18-21 suggesting that environmental or infectious factors 
are involved.1' 19 Comparing clustered to non-clustered cases may further our understanding of 
the different mechanisms that lie on the pathway to clustering of gastroschisis. For example, 
one study found higher rates of reported fever among cases that occurred in a cluster, add ing 
evidence to support involvement of an infectious agent.19 If behavioral factors, rather than 
indications of infection, appear more strongly associated with clustered cases of gastroschisis, 
then an environmental or behavior common to that area or time period may be responsible. 
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The objective of this study was to examine whether previously observed risk factors for 
gastroschisis vary in their association with gastroschisis cases that occur in temporal clusters 
using the National Birth Defects Prevention Study (NBDPS), which has the largest number of 
gastroschisis cases to date in the United States. 
3.3 METHODS 
Population Base 
The NBDPS is an ongoing multi-site population based case-control study. The goal of the 
study is to identify environmental and genetic risk factors for birth defects. Over 35 structural 
birth defects were ascertained in the study, including gastroschisis. Cases were ascertained from 
the birth defect surveillance systems in Arkansas, California, Georgia, Iowa, Massachusetts, New 
Jersey, New York, North Carolina, Texas, and Utah. All the study sites have generally similar birth 
population sizes (30,000- 80,000 births per year). In all but 2 of the states (New York and New 
Jersey) both liveborn and stillborn infants were ascertained. In 7 of the states (Arkansas, 
California, Georgia, Iowa, North Carolina, Texas, and Utah) prenatally diagnosed and electively 
terminated cases were also included. Live-born infants with no major structural malformations 
were selected as controls from birth certificates (Arkansas [2000-2003], Georgia [2001-2003], 
Iowa, Massachusetts, New Jersey, North Carolina, and Utah) and birth hospitals (Arkansas 
[1997-1999], California, Georgia [1997-2000], New York, and Texas).20.22 Data from North 
Carolina and New Jersey were not included due to logistical issues. 
Interviews 
Mothers of case and control infants were contacted and interviewed within 6 weeks to 
two years after the estimated due date (EDD) to ascertain demographic data and exposures 
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during pregnancy, including illness history, medication use, occupational history, and residential 
history from 3 months before pregnancy until birth. Participation rates for the interview were 
69% for all case mothers, 64% for gastroschisis case mothers and 66% for control mothers. 
Clinical geneticists reviewed the medical records on all cases to ensure they met the case 
definition for inclusion in the study; however, this review has only been conducted for cases 
(interviewed and non-interviewed) through 2005, therefore, the data for the present analysis 
was restricted to mothers with estimated dates of conception (EDC) between January 1997 and 
April2005. 
Covariates 
Sociodemographic factors that were assessed in this analysis included: maternal age 
(<20, 20-24, 25-29, 30-34, ~35), maternal race/ethnicity (non-Hispanic White, non-Hispanic 
Black, Hispanic, other), maternal education (<12 years, 12 years, ~12 years), income, (<$10,000, 
$10,000-50,000, ~$50,000), total number of residences (1, 2, 3, ~4), and pre-pregnancy maternal 
body mass index (<18.5, 18.5-24.9, 25-29.9, ~30). Behavioral factors that were examined 
included: alcohol use in the month prior to conception through the first 3 months of pregnancy 
(none/ yes), cigarette smoking in the month prior to conception through the first 3 months of 
pregnancy (yes/no), illicit drug use in the 3 months prior to pregnancy through the end of 
pregnancy (yes/no), any fevers reported in the first trimester (yes/no), any hot baths in the first 
trimester (yes/no), hot tub use in the first trimester (yes/no), sauna use in the first trimester 
(yes/no) and the last three categories were combined for any heat source exposure (yes/no). 
First trimester illnesses and medications were also considered and included : UTis, STDs, 
respiratory illnesses, opioid use, non-steroidal anti-inflammatory drugs (NSAIDs) use, 
decongestant use, and aspirin use. 
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Identification of clusters 
State-Time 
Two methods were used to assess temporal changes in gastroschisis rates within each 
study site . The first method (subsequently referred to as the state-time method) assessed if 
there were a high number of cases within a 30-day period. The expected number of cases in a 
30-day period was calculated for each study site . A cluster was defined as a 150% excess in the 
number of cases that had EDCs within 30 days of a case's EDC. For example, if the prevalence of 
gastroschisis was 6.7 per 10,000 live births at a study site with 36,000 births per year, then the 
expected number of cases per month would be 2. A 150% excess would be 5 or more cases in 
any 30-day period. Thus, any case that had 5 or more cases with EDCs within 30 days of its own 
EDC would be considered as having occurred in a 'cluster'. The 30-day window was calculated as 
15 days before the EDC and 15 days after the EDC. The cases that occurred within the 30-day 
window of the clustered case were also considered as occurring in that cluster. 
Hypothetical data showing the state-time method can be seen in Figure 1. In this 
example, a 150% excess (depicted by the red line) was calculated as 4.5 cases, which would 
translate to 5 or more cases in a 30 day period. All cases are indicated by yellow dots and those 
that fall into a cluster have EDCs highlighted in red text. As can be seen, all cases that fall above 
the red line are included as clusters. In addition there are a few cases below the red-line that 
also fall within 30 days of the clustered cases and would be included in the clusters. For this 
method, interviewed and non-interviewed cases from NBDPS were used in the analysis. 
Generalize Additive Models 
The second method used generalized additive models (GAMs). 23• 24 The GAM model used 
was: Log it [p(x)] = a+ y'z + S(x). The left hand side of the equation is the log of the disease odds, 
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a is the intercept, and z is a vector of the covariates. The last term is the non-parametric 
smoothing function, without which the model simplifies to an ordinary logistic regression model. 
A univariate smooth function (S(x)) was used, where x represented a unit of time. The unit of 
time for this analysis was month and year of the EDC. A loess smoother was used for the 
smoothing term because it adapts to changes in data density and weights points nearby more 
heavily than those further away. The amount of data used by the smoother was determined by 
the span size. For this analysis a span size of 0.09 was chosen, as this was the smallest span size 
that allowed the models to remain stable. A span size of 0.09 resulted in a smoothing window of 
approximately 1 year in size, which would mean predicting the odds on a given day would use 
data 6 months before and after, giving less weight to the data further away in time. For this 
method, data from interviewed cases and controls were used, which allowed for us to control 
for demographic variables ascertained from the interview. The following maternal variables 
were assessed for inclusion in the final adjusted models: maternal age (reference: Non-Hispanic 
White), maternal education (reference: >12 years of education), and maternal race/ethnicity 
(reference: ~25 years of age). The results of the two methods were compared to assess 
variations in temporal clustering that might occur due to differences in methodology. Cases 
were grouped into clustered and non-clustered cases based on the state-time method, as this 
method allowed for identification of individual cases that occurred in a cluster. Whereas, the 
smoothing function in the GAMs precluded such individual identification. A descriptive analysis 
was done comparing the distribution of sociodemographic factors, reported illnesses, and 
behavioral factors for clustered cases and non-clustered cases that had interview data available. 
Household income was the only variable with more than 10% of the data missing, therefore 
multiple imputation methods were used to impute missing data and imputed results were 
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presented separately. 
The strength of each factor was assessed using a logistic model to calculate odds ratios 
(ORs) and 95% confidence intervals (Cis); the resulting OR estimated the odds of being in a 
cluster for each of the risk factors. Adjusted odds ratios (aORs) were calculated adjusting for 
study site and maternal age. The data were also stratified by maternal age to examine if there 
were any differences by age. In addition, to further explore the possibility of interaction 
between maternal age and illnesses and medications on the additive scale (i.e. biological 
interaction) the relative excess risk due to interactions (RERis) were calculated.25 In these 
analyses, the reference group was comprised of mothers with neither the risk factor (the illness 
or medication under study) nor the modifier(~ 25 years of age). 
Figure 3.2 shows the study methods and highlights differences between the two cluster 
identification methods. 
3.4 RESULTS 
Identification of clusters 
State-time 
Using the state-time analysis, 143 interviewed cases were identified as occurring in a 
cluster, leaving 533 interviewed cases in the non-clustered group. The numbers of clustered 
cases versus non-clustered cases at each study site were as follows: Arkansas: 21 vs. 83, Atlanta: 
22 vs. 48, California : 7 vs. 165, Iowa: 21 vs. 60, Massachusetts: 27 vs. 37, New York: 19 vs. 21, 
Texas: 18 vs. 75, and Utah: 8 vs. 44. Comparing results across study sites, no coinciding trends of 
clustering or seasonal patterns were observed. 
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Generalized Additive Models 
Adjustment for maternal age, education, and race/ethnicity in the GAM method did not 
result in substantial changes to the peaks and the results were similar to the crude GAM results. 
For each study site, results from the state-time method were overlaid on the GAM results and 
are presented in Figures 3.3-3.10. When comparing the results of the two methods in the 
figures, it is important to note that the relative difference between the two lines (GAM and 
state-time) is dependent on the size of the vertical scales. For example, if the maximum value of 
they-axis for the state-time methods was doubled, the results of state-time method would 
appear much smaller in relation to the GAM method. In this example, the peaks and valleys 
would remain for the line representing the state-time method but the distance between the 
GAM line and the state-time line would now appear further away. To use a consistent 
methodology across all figures, the same specifications were used to determine the maximum 
value for the vertical axes. For the GAMs, the maximum value for they-axis was calculated by 
adding 0.5 to the highest OR detected for each study site and rounded. For the vertical axis 
presenting the state-time results, the maximum value was calculated by adding 1 to the highest 
number of cases reported . 
Results from the GAM and state-time analysis revealed similar peaks in temporal 
clustering. When clustered cases were identified by the state-time method, there was usually a 
corresponding elevation in the ORs in the GAM analysis. When comparing timing of clusters 
across the various sites no coinciding patterns were noticed. 
Clustered and Non-Clustered Comparison 
A cut-off of 1.5 was used to identify elevated ORs. Compared to non-clustered cases, 
clustered cases were more likely to have lower incomes (aOR: 2.15; 95% Cl : 0.97, 4.79), been 
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between the ages of 20 and 24 (aOR: 1.68; 95% Cl: 0.89, 3.17), lived at three residences (aOR: 
1.67; 95% Cl: 0.93, 3.00), used alcohol (aOR: 1.53; 95% Cl: 1.02, 2.29), used a sauna during their 
pregnancy (aOR: 4.62; 95% Cl: 0.60, 35.35), reported an STD (aOR: 1.59; 95% Cl: 0.53, 4.82) and 
used an opioid containing medication (aOR: 1.58; 95% Cl: 0.45, 5.58) (Table 1). 
When the data were stratified by maternal age, there were substantial differences 
between clustered and non-clustered cases among older mothers, while few aORs were 
elevated among younger mothers (Table 2). Among younger mothers, clustered cases compared 
to non-clustered cases were more likely to report sauna use (aOR: 12.31; (95% Cl: 0.83, 182.07), 
STDs (aOR: 1.99; 95% Cl: 0.62, 6.42) and opioid use (aOR: 2.27; 95% Cl: 0.57, 9.04). Among older 
moms, clustered cases were more likely to report Hispanic ethnicity (aOR: 1.70; 95% Cl: 0.33, 
8.85), lower incomes (aOR: 2.12; 95% Cl: 0.63, 7.15), more than 1 residence during pregnancy (2 
residences aOR: 1.66; 95% Cl : 0.53, 5.24; 3 residences aOR: 7.55; 95% Cl: 0.58, 97.75; ~4 
residences: aOR: 2.84; 95% Cl: 0.34, 23.89), being obese (aOR: 4.40; 95% Cl: 0.43, 45.03), alcohol 
use (aOR: 3.02; 95% Cl: 1.04, 8.79), any heat source exposure (aOR: 1.90; 95% Cl: 0.56, 6.40), 
fever (aOR: 3.50; 95% Cl: 0.73, 16.67), respiratory illnesses (aOR: 2.08; 95% Cl: 0.69, 6.24) and 
use of NSAIDs (aOR: 2.04; 95% Cl: 0.71, 5.90) in pregnancy. Of note, some of the above 
estimates were based on small numbers and therefore confidence intervals were wide. 
When assessing the joint effect of maternal age and reported illnesses and medications, 
only a few risk factors had sufficient numbers within each stratum of maternal age to perform 
the analysis. Two illnesses, UTis and respiratory infections, and two medication groups, NSAIDs 
and decongestants, were examined. All the RERis were near 0, suggesting there was no 
synergism or antagonism between the factors and maternal age (Table 3). 
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3.5 DISCUSSION 
Sporadic temporal clusters were identified in all study sites by both methodologies. Our 
findings are supported by previous research that has found gastroschisis clusters can occur in 
either space and/or time.15' 18' 26-28 The observation of clustering has led some to suggest that an 
environmental or infectious agent may be involved in the etiology of gastroschisis. 1' 19 In our 
data the lack of a coinciding trend in clustering across study sites supports this hypothesis and 
suggests that the agent varies by time and place. 
One pattern we observed in our data was that older mothers were substantially less 
likely to be included as part of a cluster. The lower rates of clustering among older mothers may 
be explained by a hypothesis proposed where an infectious agent that is more common in 
young mothers is responsible for gastroschisis.19 If clustering represents an infectious agent 
more common in younger mothers, it would not only explain why the majority of cases occurred 
to younger mothers but it could also explain the observed differences in clustering among older 
and younger mothers. Among the younger mothers (<30 years of ageL 96.6% of cases occurred 
in a cluster compared to 92.3% in the non-clustered group, given these high percentages the 
relative measure of association for clustering would be small in this case. Among the older 
mothers (~30 years of ageL the absolute difference in clustering (3 .5%) and non-clustering 
(7.7%) is the same as it is in the younger mothers (difference:::: 4%) but now because the 
outcome of clustering was less common the relative association is higher. 
A second pattern we observed with maternal age was that some of the risk factors we 
assessed in relation to clustering were stronger among older women. Previous studies have 
identified a similar pattern where risk factors were more strongly associated with gastroschisis 
among older women. For example, studies examining smoking, UTis, STDs, changes in paternity 
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between pregnancies, and occupational exposures have found that the associations with 
gastroschisis were higher among older mothers than younger mothers, though it should be 
noted these studies assessed the risk of gastroschisis, while ours examines the risk of 
gastroschisis clustering.3• 9' 10' 29-31 A previously proposed hypothesis that may shed light on these 
findings, and overlaps with the infectious agent hypothesis, proposes that the immune response 
may be involved in the pathogenesis of gastroschisis.19' 32 This hypothesis suggests that for some 
exposures the pattern of greater effects in older women may be due to the cumulative effect of 
the exposures in combination with declining immune function that occurs with increasing age, 
thereby leaving older women more susceptible to stressors such as illnesses and fevers. 22• 32 For 
example, cigarette smoking is known to affect immune function33 and older women have the 
opportunity for more years of cigarette exposure. The accumulating effect of cigarettes on 
immune function in conjunction with a decline in immune function known to occur with age34-36 
may provide an explanation for the higher risks among older mothers. In our study, older 
mothers who occur as part of a cluster may have a weaker immune system and therefore may 
be more susceptible to an infectious agent. Exposures such as alcohol use, heat source 
exposures, and residential mobility are stressors that may affect immune response, especially if 
they are repeated and long term exposures, and may serve as markers of lower immune 
function; therefore the increased risks we observe among older mothers for these exposures 
could suggest an increased susceptibility to a pathogen. 
In our data, the analysis of effect measure modification, using stratification and RERis, 
suggest that a different biological mechanism may be occurring among older women. The lack of 
elevated RERis indicated that the combination of a risk factor and maternal age did not confer 
any greater (synergism) or lower (antagonism) risk than what would be expected from the 
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independent additive effect of maternal age and the risk factor and therefore they may not 
share the same causal mechanism. For the stratified analysis, the fact that an elevated risk was 
observed for some risk factors among older mothers could indicate that a different biological 
mechanism may be involved for older women. 
There were some limitations to our study. First, not all gastroschisis cases participated in 
the NBDPS and therefore could not be included in the clustered versus non-clustered 
comparison. If participation was differential in regards to clustering and a particular risk factor, 
then our estimates could be biased. For example, if women who were part of clusters and also 
had STDs were less likely to participate, then our estimates for STDs and clustering would be 
underestimates of the true association. All the risk factors assessed were based on maternal 
report, which is susceptible to recall. Furthermore, many of our exposures of interest were 
episodic in nature and therefore may have been even more vulnerable to recall since 
pinpointing the exact timing of one episode may be difficult. When the data were stratified by 
maternal age and by various risk factors, numbers often were small, leading to wide and 
overlapping Cis. 
The strengths of this study were the use of two different analytic methods for detecting 
clusters. The use of the GAM models allowed us to adjust for covariates and included only 
interviewed cases and controls, whereas the state-time model was not adjusted and used only 
cases but included interviewed and non-interviewed subjects. Even though both methodologies 
were different, similar temporal clusters were revealed within each study center. Identifying 
temporal clusters within each study center also allowed us to account for some spatial 
variations of clustering that may have occurred across centers. An additional strength was the 
use of non-interviewed participants in the state-time cluster identification method. The 
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combination of non-interviewed and interviewed cases resulted in using all the gastroschisis 
cases born within each study site to identify temporal clusters. In addition, all cases were 
carefully reviewed by a clinical geneticist to ensure that they were true cases of gastroschisis 
and were eligible for the study. 
The results of this study suggest there may be differences in clustering patterns of 
gastroschisis cases by maternal age. This raises the question of the effect of aging within the 
child-bearing years and whether there could be a differential response to stressors or infections 
as a result of this difference. None of the stressors or infections we assessed appeared to fully 
explain the observed clustering but perhaps the observation that clustering was less common in 
older women and that there were no coinciding trends in clustering could provide clues to the 
type of stressor or infection responsible. Additional studies are needed to further explore these 
patterns and the better understand the modification by maternal age. 
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3.7 TABLES 
Table 3.1: Risk factors for clustered and non-clustered cases of gastroschisis, National Birth Defects Prevention Study, 1997-2005 
Clustered 
Non- Center Adjusted Center and Age 
N (%) clustered Crude OR OR (95% Cl) Adjusted OR N (%) (95% Cl) 
Total 143 (100) 533 (100) 
Study Center 
Arkansas 21 (14.7) 83 (15.6) 5.96 -- 5.64 (2.30, 13.84)" 
Atlanta 22 (15.4) 48 (9.0) 10.80 -- 11.54 (4.62, 28.83)" 
California 7 (4.9) 165 (31) Reference -- Reference 
Iowa 21 (14.7) 60 (11.3) 8.25 -- 8.27 (3.33, 20.53)" 
Massachusetts 27 (18.9) 37 (6.9) 17.20 -- 19.54 (7.81, 48.92)" 0'1 
-...I New York 19 (13.3) 21 (3 .9) 21.32 24.89 (9.20, 67.32)" --
Texas 18 (12.6) 75 (14.1) 5.66 -- 5.74 (2.29, 14.38)" 
Utah 8 (5.6) 44 (8.3) 4.29 -- 4.45 (1.52, 13.04)" 
Maternal age 
<20 59 (41.3) 215 (40.3) 1.07 1.48 (0.78, 2.81) 
20-24 61 (42.7) 207 (38.8) 1.15 1.68 (0.89, 3.17) 
25-29 18 (12.6) 70 (13.1) Reference Reference 
30-34 4 (2.8) 34 (6.4) 0.46 0.47 (0.14, 1.59) 
35+ 1 (0.7) 7 (1.3) 0.56 0.49 (0.05, 4.59) 
Maternal race/ethnicity 
NH White 89 (62.2) 272 (51.0) Reference Reference Reference 
NH Black 13 (9.1) 33 (6.2) 1.20 1.21 (0.56, 2.62) 1.11 (0.51, 2.43) 
Hispanic 31 (21.7) 172 (32.3) 0.55 1.08 (0.60, 1.95) 0.99 (0.55, 1.79) 
Other 10 (7 .0) 55 (10.3) 0.56 0.98 (0.45, 2.13) 0.88 (0.40, 1.95) 
Missing 0 1 
Maternal education 
<12 years 50 (35.0) 154 (28.9) 1.30 1.56 (0.94, 2.60) 1.44 (0.81, 2.55) 
12 years 51 (35.7) 204 (38.3} 1.00 1.06 (0.65, 1.73) 0.97 (0.58, 1.63) 
>12 years 39 (27.3) 156 (29 .3} Reference Reference Reference 
Missing 3 (2.0) 19 (3 .6) 
Income 
<$10,000 41 (28.7) 152 (28.5) 1.33 2.66 (1.23, 5.76) 2.15 (0.97, 4.79) 
$10-50,000 77 (53 .8) 255 (47 .8) 1.48 2.39 (1.17, 4.90) 2.05 (0.98, 4.27) 
>$50,000 12 (8.4) 59 (11.1} Reference Reference Reference 
Missing 13 (9 .1) 67 (12 .6} 
Income with imputation 
<$10,000 45 (31.5) 178 (33.4) 1.23 2.42 (1.12, 5.21) 2.09 (0.95, 4.57) 
en $10-50,000 84 (58.7) 289 (54.2) 1.39 2.15 (1.06, 4.36} 1.97 (0.96, 4.05) 
00 
>$50,000 14 (9.8) 66 (12.4) Reference Reference Reference 
Total number of residences 
1 57 (39.9) 257 (48.2) Reference Reference Reference 
2 51 (35.7) 174 (32 .6) 1.32 1.46 (0.93, 2.30) 1.36 (0.86, 2.14) 
3 26 (18.2) 69 (12 .9} 1.70 1.89 (1.07, 3.36) 1.67 (0.93, 3.00) 
4+ 7 (4.9) 18 (3.4) 1.75 1.52 (0.57, 4.04) 1.44 (0.54, 3.86) 
Missing 2 (1.4) 15 (2.8} 
Maternal body mass index 
<18.5 15 (10.5) 46 (8.6) 1.15 1.01 (0.52, 1.93) 0.92 (0.47, 1.79) 
18.5-24.9 103 (72 .0} 362 (67.9) Reference Reference Reference 
25-29.9 18 (12.6) 86 (16.1) 0.74 0.85 (0.47, 1.53) 0.95 (0.52, 1.73) 
30+ 5 (3.5) 24 (4.5) 0.73 0.80 (0.28, 2.25) 0.77 (0.26, 2.22) 
Missing 2 (1.4) 15 (2 .8) 
Alcohol use (Bl-M3) 
None 70 {49.0) 329 (61.7) Reference Reference Reference 
Yes 71 (49.7) 188 (35.3) 1.78 1.5 (1.01, 2.23) 1.53 (1.02, 2.29) 
Missing 2 (1.4) 16 (3 .0) 
Cigarette Use (Bl-M3) 
None 81 (56.6) 342 (64.2) Reference Reference Reference 
Yes 60 (42.0) 177 (33.2) 1.43 0.98 (0.64, 1.49) 0.97 (0.63, 1.48) 
Missing 2 (1.4) 14 (2 .6) 
Illicit drug use (83- DOB) 
None 123 (86.0) 453 (85.0) Reference Reference Reference 
Yes 20 (14.0) 80 (15.0) 0.92 1.04 (0.59, 1.83) 1.01 {0.57, 1.78) 
Fever in trimester 1 
en None 117 (81.8) 428 (80.3) Reference Reference Reference 
\0 
Yes 13 (9.1) 49 (9.2) 0.97 1.01 (0.51, 2.02) 1.01 (0.50, 2.03) 
Missing 13 (9.1) 56 (10.5) 
Heat/ hot water in trimester 1 
Any heat source 35 (24.5) 105 (19.7) 1.32 1.25 (0.78, 2.01) 1.24 (0.77, 2.00) 
Very hot bath 29 (20.3) 83 (15.6) 1.36 1.25 (0.76, 2.07) 1.24 (0.74, 2.06) 
Hot tub 11 (7.7) 35 (6.6) 1.16 1.17 (0.54, 2.50) 1.21 (0.56, 2.61) 
Sauna 2 (1.4) 3 (0.6) 2.46 4.27 (0.57, 31.80) 4.62 (0.60, 35.35) 
Illnesses in trimester 1 
Urinary tract infections 16 (11.2) 71 (13 .3) 0.80 0.77 (0.42, 1.43) 0.74 (0.40, 1.37) 
Sexually transmitted 5 (3.5) 19 (3 .6) 0.98 1.60 (0.54, 4.75) 1.59 (0.53, 4.82) 
diseases 
Respiratory illnesses 30 (21.0) 97 (18.2) 1.19 1.25 (0.77, 2.05) 1.32 (0.80, 2.18) 
Medications in trimester 1 
Opioids 4 (2 .8) 11 (2.1) 1.34 1.48 (0.43, 5.14) 1.58 (0.45, 5.58) 
-..J 
0 
NSAIDs 42 (29.4) 131 (24.6) 1.29 1.27 {0.82, 1.98) 
Decongestants 10 (7.0) 34 (6.4) 1.09 1.02 {0.47, 2.19) 
Aspirin 5 (3 .5) 27 (5.1) 0.68 0.81 {0.28, 2.30) 
* Analyses adjusted for center (reference: California) and maternal age (reference: 25-29) 
"Only adjusted for maternal age 
1.32 (0.84, 2.06) 
1.08 (0.50, 2.35) 
0.73 (0.25, 2.12) 
Table 3.2: Risk factors for clustered and non-clustered cases of gastroschisis stratified by maternal age, National Birth Defects Prevention 
Study, 1997--2005 
< 25 years of age ~ 25 years of age 
Clustered Non- Adjusted OR* Clustered Non- Adjusted OR* 
clustered Crude OR clustered Crude OR N (%) 
N (%) (95% Cl) N (%) N (%) (95% Cl) 
Total 120 (100) 422 (100) 23 (100) 111 (100) 
Maternal race/ethnicity 
NH White 73 (60.8) 202 (47.9) Reference Reference 16 (69.6) 70 (63.1) Reference Reference 
NH Black 12 (10.0) 26 (6.2) 1.28 1.40 (0.61, 3.21) 1 (4.3) 7 (6.3) 0.63 0.38 (0.04, 4.06) 
-....J Hispanic 26 (21.7) 147 (34.8) 0.49 0.93 (0.49, 1.75) 5 (21.7) 25 (22.5) 0.88 1.70 (0.33, 8.85) 
....... Other 9 (7.5) 46 (10.9) 0.54 0.90 (0.39, 2.06) 1 (4.3) 9 (8.1) 0.49 1.68 (0.12, 24.45) 
Maternal education 
<12 years 47 (39.2) 140 (33.2) 1.21 1.19 (0.66, 2.15) 3 (13.0) 14 (12.6) 1.02 1.43 (0.30, 6.86) 
12 years 44 (36.7) 172 (40.8) 0.93 0.82 (0.46, 1.47) 7 (30.4) 32 (28.8) 1.04 1.12 (0.37, 3.38) 
>12 years 26 (21.7) 94 (22.3) Reference Reference 13 (56.5) 62 (55.9) Reference Reference 
Income 
<$10,000 39 (32.5) 134 (31.8) 1.25 1.25 (0.51, 3.06) 2 (8.7) 18 (16.2) 0.64 1.09 (0.15, 7.99) 
$10-50,000 62 (51.7) 200 (47.4) 1.33 1.33 (0.56, 3.17) 15 (65.2) 55 (49.5) 1.58 2.12 (0.63, 7.15) 
>$50,000 7 (5.8) 30 (7.1) Reference Reference 5 (21.7) 29 (26.1) Reference Reference 
Missing 12 (10) 58 (13.7) -- -- 1 (4.3) 9 (8.1) 
Income with imputation 
<$10,000 43 (35.8) 157 (37.2) 1.17 2.01 (1.30, 5.30) 2 (8.7) 20 (18.0) 0.72 1.28 (0.18, 9.20) 
$10-50,000 68 (56.7) 230 (54.5) 1.31 1.84 (0 .74, 4.57) 16 (69.6) 59 (53.2) 1.62 2.21 (0.66, 7.41) 
>$50,000 9 (7.5) 35 (8.3) Reference Reference 5 (21.7) 32 (28.8) Reference Reference 
Total number of residences 
1 45 (37.5) 184 {43 .6) Reference Reference 12 (52.2) 73 {65.8) Reference Reference 
2 44 {36.7) 147 (34.8) 1.22 1.30 {0.79, 2.15) 7 {30.4) 27 {24.3) 1.58 1.66 (0.53, 5.24) 
3 24 (20.0) 64 {15.2) 1.53 1.48 (0 .80, 2.74) 2 (8.7) 5 (4.5) 2.43 7.55 {0.58, 97.75) 
4+ 5 (4.2) 15 (3.6) 1.36 1.19 (0.38, 3.70) 2 (8.7) 3 (2 .7) 4.06 2.84 {0.34, 23.89) 
Maternal body mass index 
<18.5 15 {12.5) 41 {9.7) 1.25 1.03 (0.52, 2.03) 0 (0.0) 5 (4.5) 
18.5-24.9 85 (70.8) 291 {69) Reference Reference 18 (78.3) 71 {64.0) Reference Reference 
25-29.9 16 {13.3) 58 {13.7) 0.94 1.32 {0.68, 2.57) 2 {8.7) 28 (25.2) 0.28 0.21 (0.04, 1.04) 
30+ 3 (2.5) 20 (4.7) 0.51 0.50 (0.14, 1.84) 2 (8.7) 4 {3.6) 1.97 4.4 (0.43, 45.03) 
Alcohol use (B1-M3) 
None 63 (52.5) 264 (62.6) Reference Reference 7 (30.4) 65 {58.6) Reference Reference 
Yes 55 (45.8) 146 {34.6) 1.58 1.37 (0.88, 2.14) 16 (69.6) 42 {37.8) 3.54 3.02 {1.04, 8.79) 
-...J Cigarette Use (B1-M3) 
tv 
None 64 (53.3) 274 (64.9) Reference Reference 17 (73.9) 68 (61.3) Reference Reference 
Yes 54 (45.0) 137 {32.5) 1.69 1.13 (0.70, 1.82) 6 {26.1) 40 {36.0) 0.60 0.31 {0.09, 1.01) 
Illicit drug use (83- DOB) 
None 102 (85.0) 356 (84.4) Reference Reference 21 {91.3) 97 {87.4) Reference Reference 
Yes 18 (15.0) 66 {15.6) 0.95 1.05 (0.57, 1.93) 2 {8.7) 14 {12.6) 0.66 0.31 (0.09, 1.01) 
Fever in trimester 1 
None 99 {82.5) 338 {80.1) Reference Reference 18 (78.3) 90 {81.1) Reference Reference 
Yes 9 (7.5) 45 {10.7) 0.68 0.72 {0.32, 1.61) 4 {17.4) 4 {3.6) 5.00 3.50 (0.73, 16.67) 
Heat I hot water in trimester 1 
Any heat source 29 (24.2) 85 {20.1) 1.26 1.14 (0.67, 1.91) 6 (26.1) 20 {18.0) 1.61 1.90 {0.56, 6.40) 
Very hot bath 24 (20.0) 68 {16.1) 1.28 1.13 (0.65, 1.97) 5 (21.7) 15 {13.5) 1.72 1.65 {0.44, 6.20) 
Hot tub 9 (7.5) 25 (5.9) 1.27 1.26 (0.53, 2.96) 2 (8.7) 10 (9.0) 0.92 1.61 {0.23, 11.54) 
Sauna 2 {1.7) 1 (0.2) 7.01 12.31 (0.83, 182.07) 0 (0.0) 2 {1.8) 
Illnesses in trimester 1 
Urinary tract infections 15 {12.5) 59 {14) 0.86 0.83 {0.43, 1.60) 1 {4.3) 12 {10.8) 0.36 0.34 {0.03, 3.33) 
Sexually transmitted 5 {4.2) 13 {3.1) 1.37 1.99 {0.62, 6.42) 0 {0.0) 6 {5.4) diseases 
Respiratory illnesses 22 (18 .3) 75 (17.8) 1.04 1.13 (0.64, 1.99) 8 (34.8) 22 (19.8) 2.16 2.08 (0.69, 6.24) 
Medications in trimester 1 
Opioids 4 {3.3) 7 (1.7) 2.02 2.27 {0.57, 9.04) 0 (0.0) 4 (3 .6) 
NSAIDs 33 (27.5) 101 (23.9) 1.23 1.18 (0.71, 1.96) 9 (39.1) 30 (27.0) 1.65 2.04 (0.71, 5.90) 
Decongestants 9 (7.5) 25 (5.9) 1.30 1.21 (0.52, 2.82) 1 (4.3) 9 (8.1) 0.47 0.35 (0.04, 3.13) 
Aspirin 5 (4.2) 25 (5.9) 0.69 0.73 (0.25, 2.14) 0 (0.0) 2 {1.8) 
*Analyses adjusted for center (reference: California) 
-..1 
w 
Table 3.3 : The odds ratio for the joint effect of young maternal age and selected illnesses and 
medications, National Birth Defects Prevention Study, 1997-2005. 
Risk Factor 
Urinary tract 
infections 
No 
No 
Yes 
Yes 
Respiratory 
infections 
No 
No 
Yes 
Yes 
NSAID use 
No 
No 
Yes 
Yes 
Decongestant use 
No 
No 
Yes 
Yes 
Young 
maternal age 
(<25 years) 
No 
Yes 
No 
Yes 
No 
Yes 
No 
Yes 
No 
Yes 
No 
Yes 
No 
Yes 
No 
Yes 
Crude OR 
(95% Cl) 
Reference 
0.36 (0.04, 2.89) 
1.26 {0.76, 2.10) 
1.09 {0.52, 2.26) 
RERI : 0.47 {-0.55, 1.49) 
Reference 
2.16 {0.81, 5.73) 
1.68 {0.93, 3.03) 
1.74 {0.84, 3.59) 
RERI: -1.09 {-3.37, 1.18) 
Reference 
1.65 {0.65, 4.21) 
1.46 {0.79, 2.71) 
1.80 {0.90, 3.59) 
RERI : -0.31 {-1.95, 1.33) 
Reference 
0.47 (0.06, 3.90) 
1.17 {0.70, 1.95) 
1.52 {0.62, 3.72) 
RERI: 0.88 (-0.65, 2.42) 
* Analyses adjusted for center (reference: California) 
RERI : Relative excess risk due to interaction 
74 
Adjusted OR * 
(95% Cl) 
Reference 
0.29 {0.03, 2.47) 
1.75 {1.00, 3.05) 
1.48 {0.67, 3.27) 
RERI : 0.45 {-0.74, 1.63) 
Reference 
2.37 {0.84, 6.70) 
2.42 {1.28, 4.57) 
2.70 {1.23, 5.93) 
RERI : -1.09 {-3 .90, 1.72) 
Reference 
1.89 {0.70, 5.14) 
2.17 {1.11, 4.23) 
2.57 {1.22, 5.44) 
RERI: -0.49 {-2.65, 1.67) 
Reference 
0.43 (0 .05, 3.77) 
1.65 (0.94, 2.87) 
2.07 (0.79, 5.40) 
RERI: 0.99 (-0.96, 2.94) 
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Figure 3.1: Methodology ofthe state-time analysis using hypothetical data with an expected 1.8 cases per month 
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Figure 3.3: Results of generalized additive models (cases: n=134 and controls: n=1071) and state-time analysis (cases: n=145), Arkansas, 
1997-2005 
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Figure 3.4: Results of generalized additive models (cases: n=lOS and controls: n=893) and state-time analysis (cases: n=l09), Atlanta, 
1997-2005 
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Figure 3.7: Results of generalized additive models (cases: n=80 and controls: n=1033) and state-time analysis (cases: n=107}, 
Massachusetts, 1997-2005 
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Figure 3.8: Results of generalized additive models (cases: n=48 and controls: n=732) and state-time analysis (cases: n=65), New York, 
1997-2005 
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Figure 3.9: Results of generalized additive models (cases: n==105 and controls: n==893) and state-time analysis (cases: n==164), Texas, 
1997-2005 
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Figure 3.10: Results of generalized additive models (cases: n=86 and controls: n=618) and state-time analysis (case: n=72), Utah, 2002-
2005 
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4 GENITOURINARY INFECTIONS AND THE RISK OF GASTROSCHISIS 
4.1 ABSTRACT 
Genitourinary infections (GUis) have been associated with an increased risk of gastroschisis in 
two studies. Odds ratios (ORs) from these studies were 2.6 for women who reported any history 
of gynecological infections and 1.4 for a reported GUI. Using data collected in the Boston 
University Slone Epidemiology Birth Defects Study, we examined the association between GUI 
and gastroschisis. From 1998-2010, mothers of 249 gastroschisis cases and 7,104 controls were 
interviewed within 6 months of delivery about pregnancy events and exposures, including 
vaginal infections, genital herpes, urinary tract infections (UTis), and other sexually transmitted 
diseases (STDs). Women were considered exposed if they reported at least one instance of a 
GUI in the first trimester. Logistic regression models were used to calculate ORs and 95% 
confidence intervals {Cis). Women who reported having any GUI had an adjusted OR of 1.8 
(95%CI : 1.3, 2.4). The highest risk was among women who reported a UTI only (adjusted OR: 2.3; 
95%CI: 1.5, 3.5), while OR for STDs only were slightly elevated (adjusted OR: 1.2; 95%CI: 1.0, 
1.5). Among women younger than 25 years of age the OR for only UTis was 2.6 (95%CI: 1.7, 4.0) 
and among older women the OR was 1.8 (95%CI: 0.6, 5.9). When we considered the joint effect 
of UTis and young maternal age, a synergistic effect was observed. The results of this study add 
further evidence that UTis may increase the risk of gastroschisis. 
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4.2 INTRODUCTION 
Several embryologic hypotheses have been proposed for the development of 
gastroschisis. The prevalent hypothesis is that gastroschisis occurs when there is a vascular 
disruption of the right omphalomesenteric artery, which leads to a weakening at the base of the 
umbilical cord and results in herniation ofthe gut.1' 2 There is some epidemiologic data to 
support this vascular disruption hypothesis. First, gastroschisis has been found to occur in 
conjunction with other vascular disruption defects. 1' 3' 4 Additionally, gastroschisis has been 
positively associated with vasoconstrictive exposures such as cocaine use, amphetamine use, 
and smoking. s-s It has also been associated with vasoactive medications, including 
pseudoephedrine, phenylpropanolamine, aspirin, ibuprofen, and acetaminophen. 2' 6' 9-12 While 
the mechanisms for these medications vary, they all indicate an underlying infection in the 
mother. Furthermore infections in pregnancy and the corresponding inflammatory response 
have been found to trigger a series of events that have effect on the vasculature and can result 
in vasodilation or vasoconstriction depending on the setting.13 
Genitourinary infections (GUis) are one type of infection that has been associated with 
an increased risk of birth defects.14-16 To date, two studies have linked GUis with gastroschisis. 
The first study was conducted in the United Kingdom and found a 2.6-fold increased risk of 
gastroschisis for women with any prior history of gynecologic infection or disease.6 The second 
study found the greatest risk was among women who reported both a sexually transmitted 
disease (STD) and urinary tract infection (UTI) in the first trimester.17 
The objective ofthis study was to examine the association between GUis and 
gastroschisis using data collected in a large case-controls study on birth defects. In addition, the 
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independent effects of STDs and UTis were evaluated, as well as whether maternal age modified 
the association between GUis and gastroschisis. 
4.3 METHODS 
Study Design 
The Pregnancy Health Interview Study (also known as the Birth Defects Study) is an 
ongoing multicenter case-control study that aims to assess risk factors in relation to birth 
defects and has been previously described in detail. 18. 20 The study began ascertaining cases in 
1976 from birth hospitals and tertiary-care centers in the US and Canada. Potential cases were 
identified by reviewing discharge lists, clinical and surgical logs, and through newborn nurseries. 
Study staff did not consistently ascertain therapeutic abortions or fetal deaths after 20 weeks, 
but mothers' of cases with these outcomes were eligible for the study. Non-malformed live-born 
controls were ascertained from the same birth hospitals as cases or from statewide birth 
records. 
The present study was restricted to women interviewed between 1998 and 2010. 
During this time subjects were recruited from the greater metropolitan areas of Philadelphia, 
Pennsylvania; San Diego, California; Toronto, Canada; and from Massachusetts and New York 
State. Cases of gastroschisis were confirmed by medical records (available for 64.3% of cases) 
and were further classified as isolated or associated. Isolated cases only had gastroschisis 
present and no other major malformation, while associated cases had at least one other 
unrelated major malformation. Infants with chromosomal anomalies, Mendelian inherited 
disorders, or a known syndrome were excluded. 
Telephone interviews were conducted in English and Spanish with the mothers of cases 
and controls by trained nurses within 6 months of delivery. After oral consent was obtained 
87 
women were asked about demographic information, vitamin use, reproductive and medical 
history, illnesses and medications, cigarette smoking, alcohol and caffeine intake, and diet using 
a standardized questionnaire. 
Exposure 
Detailed information was obtained on illnesses and medications from 2 months prior to 
the last menstrual period (LMP) through the end of pregnancy. A tiered approach was used to 
obtain information on illnesses and medications.21 Women were first questioned on specific 
illnesses, including "UTis", "yeast/vaginal infections", "genital herpes", and "any other STDs." If 
a woman responded positively, she was asked about illness dates, if any medications were used 
and if a fever occurred in conjunction with the illness. Next, independent of their responses to 
the illness questions, women were asked about any medications they took and were prompted 
with a list of specific medications including zovirax and acyclovir. If a woman reported using a 
medication, the dates and indication for use were noted. 
Mothers were considered exposed if they reported at least one instance of either a GUI 
or used a medication and reported it was for a GUI anytime in the first three lunar months after 
the last menstrual period (i.e ., the first trimester). Four mutually exclusive exposure categories 
were created: 1) report of a UTI alone 2) a STD alone 3) both a UTI and a STD 4) no UTI and no 
STD. In addition, categories 1 through 3 were collapsed to examine reports of either a UTI or a 
STD. Mothers were excluded if they reported GUI dates that were unclear or missing. 
The class of medications reported for GUis were compared between cases and controls. 
The type of medication was also assessed and included over the counter medications (OTC), 
prescription medications, and alternative therapies (e.g., herbal remedies, vitamins, and 
douches). When looking at the type of medications, the following were assumed to be 
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prescription medications: not otherwise specified (NOS) urinary tract medication, NOS STD 
medication, NOS herpes medication, NOS antibiotic medication, and NOS urinary tract infection 
medication. The following NOS medications were placed in the unknown category, as it could 
not be determined if they were OTC or prescription medications: NOS vaginal anti-infective 
medication, NOS anti-fungal medication, NOS vaginal cream, and NOS vaginal suppository. In 
addition, we stratified the data to assess if treatment patterns varied for younger compared to 
older mothers. 
Statistical Analysis 
Odds ratios (ORs) and 95% confidence intervals (CI) were calculated for each exposure 
group with women who reported no UTis and no STDs serving as the reference. Confounders 
that were considered included: study center(Massachusetts, Philadelphia, Toronto, San Diego, 
New York), race/ethnicity (non-Hispanic white, non-Hispanic black, Hispanic, Asian, other), 
maternal education (<high school, high school, >high school), maternal age (<20, 20-24, 25-29, 
30-34, 35+), pregnancy intention (planned, unplanned), body mass index (<18.5, 18.5-24.9, 25-
29.9, 30+), maternal smoking (never or before pregnant, smoked in first trimester), alcohol 
consumption (never or before pregnant, drank in first trimester), illicit drug use (never or before 
pregnant, used in first trimester), multivitamin use (no use, use in first trimester), and any fevers 
reported in the first trimester (yes/no). To identify the final list of confounders, crude ORs were 
calculated and each potential confounder was added to the model. The strongest confounder 
that changed the estimate by more than 10% was added to the model and each potential 
confounder was once again assessed. This process was repeated until no variables were left that 
changed the estimate by more than 10%. To assess the possibility of a non-linear relationship 
between maternal age and the log odds of gastroschisis a restricted cubic spline was used along 
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with a test for non-linearity. The test for nonlinearity used the likelihood ratio test and 
compared the model with only the linear term to the model with the linear and the cubic spline 
terms; if the test returned a small p-value the relationship between maternal age and the 
outcome was considered to be non-linear.22 A stratified analysis was conducted to assess 
whether effect measure modification by maternal age was present. In addition, to further 
explore the possibility of interaction on the additive scale (i.e. biological interaction) the relative 
excess risk due to interaction (RERI) was calculated, with the reference group comprised of older 
mothers(~ 25 years of age) without the exposure (no UTis and no STDs). 
Fever (~101 oF) in conjunction with an infection can indicate a more severe infection; 
therefore a sub-analysis was conducted to examine the effects of a severe GUI, using fever as a 
proxy for severity, and the risk of gastroschisis. In the sub-analysis, mothers were considered 
exposed if they reported that they experienced a fever with their GUI and were compared to 
women who reported no GUis (and consequently had no fevers from a GUI). To assess the 
possibility that fever from other indications might be an independent risk factor, the analysis 
was rerun excluding women who reported fevers from other indications (e.g., respiratory 
illnesses or flu) . A second sub-analysis was performed to assess if multivitamin use (either 
multivitamins or prenatal vitamins) in the first trimester might alter the effects of GUis, given 
that various vitamins have been found to enhance immune response23 and reduce the risk of 
birth defects.19 In addition, a separate analysis was conducted restricting the cases to only the 
isolated cases of gastroschisis. 
A sensitivity analysis was conducted to examine the possibility of recall bias. Reported 
exposures after the etiologically relevant time period were examined. Mothers who reported a 
GUI in only the second or third trimester were considered exposed and compared to those 
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mothers who reported no GUis in the same time period. The expectation was that recall bias 
would be less likely to affect reports of exposure timing; therefore there would be less concern 
of recall bias if the effect was confined to the etiologically relevant time period. 
Due to methods of case and control ascertainment, a second sensitivity analysis was 
performed to assess the possibility of selection bias. When ascertaining controls, a control could 
have come from a study hospital from which we had no gastroschisis cases; if this were the case, 
then the control population may not represent the base population that gave rise to the cases. 
To address this possibility the sensitivity analysis restricted cases and controls to those chosen 
from the same birth hospitals 
4.4 RESULTS 
There were a total of 249 cases and 7,104 controls identified. Compared with cases, 
control mothers were more likely to be non-Hispanic white, older, more educated, non-
smokers, have planned their pregnancy, and had previous pregnancies {Table 4.1) . Reports of 
any GUI were more common in case mothers {29%) than in control mothers {15%) (Table 4.2). 
Mothers of cases also reported a higher percentage of only STDs {13%) and only UTis {13%) than 
mothers of controls {10% and 4%, respectively). The breakdown of STD types for the 40 case 
mothers who reported an STD was as follows: 5% genital herpes, 63% vaginal/yeast infections, 
23% other STDs, and 10% reported a combination of STD types. Among the 756 control mothers 
who reported an STD the types were as follows: 15% genital herpes, 77% vaginal/yeast 
infections, 5% other STDs and 3% reported a combination of STD types. 
The results of the cubic spline {Figure 1) indicated that young maternal age was strongly 
associated with gastroschisis but not in a linear fashion (p-value <0.05L therefore maternal age 
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was modeled as a categorical variable. The multivariate adjusted models included maternal age, 
as it was the only covariate that met the criterion for confounding. Women who reported having 
any GUI had an adjusted OR of 1.8 (95% Cl: 1.3, 2.4) compared to mothers who reported no GUI 
(Table 4.2) . The highest risk was among women who reported only a UTI (adjusted OR: 2.3; 95% 
Cl : 1.5, 3.5) . 
When the data were stratified by maternal age, none of the potential confounders met 
the criteria for inclusion in the model, therefore crude ORs were reported. A stronger 
association was observed among younger mothers for UTis only and the risk of gastroschisis 
(OR: 2.6; 95% Cl: 1.7, 4.0). All other estimates were similar for younger mothers compared with 
older mothers (Table 4.3). 
When the joint effects of young maternal age and reported infection were assessed, 
maternal education and maternal smoking were identified as confounders and included in the 
adjusted models. A synergistic effect was seen between GUis and maternal age, with the effect 
being strongest for UTis only (Table 4.4) . The adjusted ORs for the joint effect between young 
maternal age and UTis only was 24.8 (95%CI: 14.2, 76.2) compared to older women with no 
GUis, resulting in a RERI of 13.2 (95% Cl: 1.5, 25.0). 
Among mothers with a GUI, the proportion of cases (88%) reporting a treatment 
(medication or alternative therapies) for GUis was slightly higher than for controls (82%). When 
comparing classes of medications, anti-infectives were the most common class of medications 
reported (Table 4.5). Among younger mothers, cases compared to controls reported a higher 
percentage of anti-virals (3.1% and 0.3%, respectively) and unknown anti-infectives (60.9% and 
54.2%, respectively); while among older mothers, cases reported more usage of anti-bacterial 
medications than controls (33.3% and 7.4%, respectively). When comparing types of 
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medications reported, control mothers (25%) were more likely to use an OTC medication 
compared to cases (11%). When the data were stratified by age, older case mothers (67%) were 
more likely to report taking a prescription medication than older control mothers (42%). 
Reports of fever were made only in conjunction with UTis. Among mothers who 
reported a UTI, 6.1% of cases and 2.9% of controls reported a UTI with a fever. The OR 
comparing mothers with a UTI and a fever to those with no GUis was 5.4 (95% Cl: 1.0, 30.3) 
adjusting for maternal age (Table 4.6a). When mothers who reported fevers from other 
indications (e.g., flu, respiratory illnesses, etc.) were removed, the OR doubled (OR: 11.2; 95% 
Cl: 1.3, 93.0), suggesting that the combination of fever and UTis increased the risk of 
gastroschisis not just fever alone. 
When the data were stratified by multivitamin use in the first trimester, estimates 
changed little for multivitamin users, but mothers who reported no multivitamin use were at 
increased risk (Table 4.7) . The adjusted OR for UTis and gastroschisis increased to 5.7 (95% Cl: 
2.5, 12.9) among women who reported no multivitamin use. 
Only 11 cases had other major malformation and none were in the exposed group, 
therefore the results did not change substantially when the case group was restricted to the 238 
isolated cases of gastroschisis (Table 4.8). In addition, second and third trimester exposures did 
not result in elevated ORs, reducing the likelihood that the results were due to recall bias (Table 
4.9). When the data were restricted to cases and controls that came from the same birth 
hospitals, the ORs were further elevated compared to the main analysis, but the overall 
interpretation of the results remained the same (Table 4.10). 
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4.5 DISCUSSION 
The results of this study suggest that reported UTis in the first trimester increase the risk 
of gastroschisis. Little effect was observed for reported STDs and the risk of gastroschisis. The 
OR for UTis only was higher among younger mothers and a synergistic effect was observed for 
the joint effect of UTis and young maternal age. 
Our results are similar to findings from two previous studies that looked at GUis and 
gastroschisis. The first study used data from the United Kingdom and reported an adjusted OR of 
2.6 (95% Cl: 1.2, 5.6) when examining any history of prior gynecologic infection or disease and 
the risk of gastroschisis.6 While the results of the British study showed an elevated risk, the 
exposure definition was nonspecific both in regards to type and the timing of infection. The next 
study conducted by Feldkamp et al. was able to refine the definition of exposure, while also 
narrowing down the exposure window to the first trimester. 17 The Feldkamp et al. study used 
data from the National Birth Defects Prevention Study and found the largest association was 
among mothers who reported both a UTI and a STD, with an OR of 3.9 (95% Cl : 1.4, 10.8) after 
adjustment for maternal age.17 The adjusted OR for only STDs was the same as in our study 
(adjusted OR: 1.2; 95% Cl: 0.7, 2.2); however, their estimate for UTis, while elevated, was lower 
than ours (adjusted OR: 1.4; 95% Cl: 1.0, 1.9}. When the data were stratified by maternal age, 
the authors found that even though younger mothers were more likely to report UTis than older 
mothers, the association between UTis and gastroschisis was lower among younger mothers. 
For UTis only, the OR was 1.3 (95% Cl: 0.8, 2.0) for younger mothers (<20 years of age) and 2.3 
{95% Cl : 0.7, 7.6) for older mothers (~30 years of age). A similar pattern was reported for STDs 
only, with an OR of 1.3 (95% Cl: 0.6, 3.0) and 4.9 (95% Cl: 1.1, 21.9) among younger and older 
mothers, respectively. The higher OR among older mothers could be due to a lower baseline risk 
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for gastroschisis in the older women, resulting in a smaller denominator and an overall larger OR 
within the strata. To address this issue, the present analysis both stratified by maternal age and 
assessed the joint effect of maternal age and GUI using a common reference group. 
There are multiple mechanisms by which GUis may act to increase the risk of gastroschisis. 
The first may be through medications used to treat GUis, though as seen in our study the 
treatments for GUis varied widely from homeopathic remedies to antibacterials to antivirals and 
make it unlikely that treatments may be responsible. The mechanism could also be through the 
direct insult of the virus or bacteria. However for UTis, multiple pathogens have been indicated 
as common causes and it's unlikely that varying bacteria (e.g. escherichia coli and chlamydia 
trachomatis), viruses (e.g. herpes simplex virus), and parasites (e.g. trichomoniasis) would all 
have the same mechanistic action and be at fault. 24" 25 Another mechanism may be due to the 
immune response from an infection. One hypothesis put forward is that the maternal immune 
response to an infection could have effects on fetal development via maternal antibodies 
passed through the placenta.26 Alternately, the maternal or fetal immune response to an 
infection could disrupt the embryonic developmental pathways. Evidence of this is found in 
previous studies where maternal infection, hyperthermia, and fevers were associated with 
changes in maternal vasculature or apoptosis in the embryo.13• 27-29 In our data fever was not 
strongly associated with gastroschisis overall (3.2% of cases compared to 2.5% of controls 
reported fevers in the first trimester), but when a mother reported a UTI that led to a fever, the 
risk of gastroschisis was much stronger than the risk from a UTI alone. If fever in conjunction 
with a UTI indicated a more severe infection, then this would add further evidence to the 
hypothesis that immune response may be involved in the etiology of gastroschisis. It has also 
been posited that the elevated risk in younger mothers could be the result of an immune 
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response to new pathogens. In particular, younger mothers would have less cumulative 
exposure to GUis and are more likely to have changes in partners between pregnancies, which 
would expose them to new paternal antigens. To date, three studies have found that changes in 
paternity or short sexual cohabitation times increased the risk of gastroschisis adding further 
evidence to this hypothesis.30-32 
There have been some studies that suggest multivitamin use may reduce the risk of birth 
defect from maternal infections and fever.33-35 In our study risks remained elevated among 
multivitamin users, however mothers who reported no multivitamin use in the first trimester 
were at further increased risk of gastroschisis. One mechanism proposed is that folic acid may 
rescue folate deficient cells from apoptosis, which is important in many stages of embryonic 
development.36-38 Other studies have suggested that antioxidants may effect development by 
reducing reactive oxidative species, which is responsible for mediating apoptosis and cell 
elimination.29 
There were some limitations to our study. First, some mothers may have had subclinical 
GUis and were included in the unexposed category which could lead to an underestimation of 
the true risk. Secondly, even though a large number of potential confounders were examined, 
we cannot rule out the possibility of residual confounding affecting our results. We also did not 
have information on inter-pregnancy interval, changes in paternity, or cohabitation time with a 
partner, all of which have been associated with gastroschisis. In addition, we relied on maternal 
report of GUis, which may be susceptible to reporting bias, though the use of a standardized 
questionnaire reduced the likelihood oft his type of bias. In fact, one of the strengths of this 
study was the tiered approach to obtaining information on medication and illnesses, which 
resulted in detailed exposure information. Additionally, the short interval between delivery and 
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interview(!> 6 months) reduced concerns regarding reporting accuracy. There were two 
methodological strengths of our study. The first was the use of a sensitivity analysis to assess the 
possibility of recall bias and the second was the assessment of both effect measure modification 
and biological interaction by maternal age. 
The results of our study add to the evidence that UTis may increase the risk of gastroschisis. 
This study is the first to assess and identify a synergistic relationship between young maternal 
age and UTis. Further studies are needed to confirm this synergistic effect; in addition, 
identifying pathogens and measuring markers of inflammatory response may help elucidate the 
underlying mechanism at play. 
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4.7 TABLES 
Table 4.1 : Characteristics of women who had an infant with gastroschisis and women whose 
infants had no major malformations, United States and Canada, 1998-2010. 
Case Control 
N % N % 
Total 249 100.0% 7104 100.0% 
Maternal race 
Non-Hispanic White 135 54.2% 5013 70.6% 
Non-Hispanic Black 28 11.2% 529 7.4% 
Hispanic 68 27.3% 1025 14.4% 
Asian 9 3.6% 385 5.4% 
Other 9 3.6% 146 2.1% 
Missing 0 0.0% 6 0.1% 
Maternal age 
<20 109 43.8% 500 7.0% 
20-24 93 37.3% 1006 14.2% 
25-29 30 12.0% 1841 25.9% 
30-34 12 4.8% 2424 34.1% 
35+ 5 2.0% 1313 18.5% 
Missing 0 0.0% 20 0.3% 
Education 
< 12 years 65 26.1% 650 9.1% 
12 years 93 37.3% 1302 18.3% 
> 12 years 91 36.5% 5147 72.5% 
Missing 0 0.0% 5 0.1% 
Center 
Boston 43 17.3% 3831 53.9% 
Ph illy 89 35.7% 1349 19.0% 
Toronto 28 11.2% 644 9.1% 
San Diego 51 20.5% 930 13.1% 
New York 38 15.3% 350 4.9% 
Maternal body mass index 
Missing 3 1.2% 157 2.2% 
<18.5 23 9.2% 417 5.9% 
18.5-< 25 170 68.3% 4377 61.6% 
25-<30 46 18.5% 1367 19.2% 
30+ 7 2.8% 786 11.1% 
Maternal report of smoking in 1st trimester 
No 138 55.4% 5922 83.4% 
Smoked during pregnancy 111 44.6% 1181 16.6% 
Unknown 0 0.0% 1 0.0% 
Maternal report of alcohol use in 1st trimester 
Never or before pregnancy 147 59.0% 3973 55.9% 
101 
Drank during pregnancy 102 41.0% 3131 44.1% 
Recreational drug use 
No 230 92.4% 6978 98.2% 
Yes 19 7.6% 126 1.8% 
Pregnancy intention 
Unplanned pregnancy 162 65.1% 2624 36.9% 
Planned pregnancy 87 34.9% 4480 63.1% 
First pregnancy 
No 116 46.6% 4909 69.1% 
Yes 133 53.4% 2195 30.9% 
First trimester multivitamin use 
No 46 18.5% 742 10.4% 
Yes 201 80.7% 6294 88.6% 
Missing 2 0.8% 68 1.0% 
Any Fever in the first trimester 
No 241 96.8% 6923 97.5% 
Yes (~101 o F) 8 3.2% 181 2.5% 
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Table 4.2: Odds ratio for the risk of gastroschisis according to genitourinary infection in the first trimester of pregnancy, United States 
and Canada, 1998-2010. 
Cases Controls Crude Adjusted* 
N % N % OR 95%CI OR 95%CI 
NoSTD or UTI 176 71% 6036 85% Reference Reference 
STD or UTI 73 29% 1068 15% 2.35 1.77, 3.10 1.76 1.31, 2.37 
UTI only 33 13% 312 4% 3.63 2.46, 5.35 2.31 1.53, 3.51 
STD only 33 13% 678 10% 1.29 1.07, 1.56 1.20 0.98, 1.46 
STD and UTI 7 3% 78 1% 1.46 1.12, 1.89 1.22 0.93, 1.61 
*Adjusted for maternal age (Referent: 25-29 years of age) 
!-> 
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Table 4.3: Odds ratio for the risk of gastroschisis according to genitourinary infection in the first trimester of pregnancy stratified by 
maternal age, United States and Canada, 1998-2010. 
< 25 years of age ~ 25 years of age 
Cases Controls Crude OR 95%CI Cases Controls Crude OR 95%CI N (%) N (%) N (%) N (%) 
NoSTD or UTI 138 (68%) 1211 (80%) Reference 38 (81%) 4807 (86%) Reference 
STD or UTI 64 (32%) 295 (20%) 1.90 1.38, 2.63 9 (19%) 771 (14%) 1.48 0.71, 3.07 
UTI only 30 (15%) 102 (7%) 2.58 1.66, 4.02 3 (6%) 210 (4%) 1.81 0.55, 5.90 
STD only 28 (14%) 164 (11%) 1.22 0.98, 1.52 5 (11%) 512 (9%) 1.11 0.70, 1.78 
STD and UTI 6 (3%) 29 (2%) 1.22 0.91, 1.65 1 (2%) 49 (1%) 1.37 0.70, 2.68 
1-" 
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Table 4.4: The odds ratio for the joint effect of young maternal age and genitourinary infections, United States and Canada, 1998-2010. 
Young maternal age 
No 
No 
Yes 
Yes 
UTI only OR* (95%} 
No Reference 
Yes 1.8 (0.6, 6.0) 
No 10.7 (7.2, 16.0) 
Yes 24.8 {14.2, 76.2) 
RERI: 13.2 {1.5, 25.0) 
Young maternal age STD only OR* (95%} 
No No Reference 
No Yes 1.2 (0.5, 3.0) 
Yes No 10.8 {7.3, 16.1) 
Yes Yes 15.5 (9.0, 26.7) 
RERI: 4.5 (-2.3, 11.4) 
*Analyses adjusted for education (reference: 12 years) and smoking (reference: no) 
RERI: Relative excess risk due to interaction 
Table 4.5: Medication types reported in the first trimester of pregnancy for genitourinary infections, stratified by maternal age, United 
States and Canada, 1998-2010. 
Maternal age <25 Maternal age >25 Total 
Cases Controls Cases Controls Cases Controls 
n(%) n(%) n(%) n(%) n(%) n(%) 
Total with STD or UTit 64 295 9 771 73 1066 
Class of medication reported* 
Anti-infectives 
Antibacterial 5 (7 .8) 31 {10.5) 3 (33.3) 57 (7.4) 8 {11.0) 88 {8.3} 
Antifungal 9 {14.1) 66 (22.4) 1 {11.1) 226 {29.3} 10 {13.7) 292 (27.4) 
Antiprotozoal 1 {1.6) 4 {1.4) 0 (0.0) 9 {1.2) 1 {1.4) 13 (1.2) 
Antiviral 2 (3.1) 1 (0.3) 0 {0.0} 25 {3.2) 2 (2.7) 26 (2.4) 
Urinary anti-infective 2 (3.1) 9 {3.1) 1 {11.1) 24 (3.1) 3 (4.1) 33 (3.1) 
....... 
Anti-infective unknown 39 (60.9) 160 (54.2) 3 {33.3} 320 {41.5) 42 (57.5) 480 (45.0) 
0 Analgesics 0 (0.0) 2 (0.7) 0 (0.0) 3 (0.4) 0 (0.0) 5 (0.5) 0'\ 
Alternative therapies 1 {1.6) 2 (0.7) 0 {0.0} 20 (2 .6) 1 (1.4) 22 (2.1) 
Unknown medication 2 (3 .1) 0 (0.0) 0 (0.0) 0 (0.0) 2 (2 .7) 0 {0.0} 
Type of medications reported* 
Over the counter 8 {12.5) 55 {18.6) 0 (0.0) 212 (27.5) 8 {11.0) 267 {25.0) 
Prescription 39 (60.9) 155 (52.5) 6 {66.7) 321 {41.6) 45 {61.6} 476 (44.7) 
Alternative therapies~ 1 {1.6) 2 {0.7) 0 (0.0) 20 (2.6) 1 (1.4) 22 (2 .1) 
Unknown typeA 15 (23.4) 70 (23.7) 1 {11.1) 151 {19.6) 16 {21.9) 221 (20.7) 
t The total number of exposed served as the denominator for the calculated percentages in the table 
* More than 1 type of medication could be reported and therefore columns do not sum to the total 
~Alternative therapies included herbal remedies, vitamins, and therapies such as douches 
A Unknown type includes not otherwise specified medications which could not be classified into a specific type (e .g., Not 
otherwise specified antifungal medication) 
...... 
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Table 4.6: Odds ratio for risk of gastroschisis according to urinary tract infections in conjunction with fevers in the first trimester of 
pregnancy, when all mothers are included (a) and when restricted to mothers with no reported fevers for other indications (b), United 
States and Canada, 1998-2010 
a) 
Cases Controls Crude Adjusted* 
N % N % OR (95% Cl) OR (95% Cl) 
No STI or UTI 176 99% 6036 100% Ref Ref 
UTI with a fever 2 1% 10 0% 6.9 (1.5, 31.5) 5.4 (1.0, 30.3) 
b) 
Cases Controls Crude Adjusted* 
N % N % OR (95% Cl) OR (95% Cl) 
No STI or UTI or fevers in 
176 99% 5906 100% Ref Ref the first trimester 
UTI with a fever but no 2 1% 3 0% 22.4 (3.72, 134.9) 11.2 (1.3, 92.97) 
other fevers reported 
*Adjusted for maternal age (Referent: 25-29 years of age) 
...... 
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Table 4.7: Odds ratio for the risk of gastroschisis according to genitourinary infection in the first trimester of pregnancy stratified by first 
trimester multivitamin use, United States and Canada, 1998-2010. 
Cases Controls Crude Adjusted* 
N % N % OR 95%CI OR 95%CI 
No reported multivitamin use 
No STI or UTI 28 61% 642 87% Reference Reference 
STI or UTI 18 39% 100 13% 4.13 2.20, 7.74 3.30 1.73, 6.29 
UTI only 11 24% 30 4% 8.41 3.82, 18.48 5.69 2.51, 12.89 
STI only 5 11% 62 8% 1.36 0.83, 2.23 1.30 0.78, 2.14 
STI and UTI 2 4% 8 1% 1.79 1.05, 3.05 1.55 0.90, 2.67 
Reported multivitamin use 
NoSTI or UTI 148 74% 5340 85% Reference Reference 
STI or UTI 53 26% 954 15% 2.01 1.45, 2.76 1.53 1.09, 2.14 
UTI only 22 11% 278 4% 2.86 1.80, 4.54 1.91 1.17, 3.11 
STI only 26 13% 607 10% 1.24 1.01, 1.54 1.14 0.91, 1.42 
STI and UTI 5 2% 69 1% 1.38 1.01, 1.88 1.18 0.85, 1.63 
*Adjusted for maternal age {Referent: ~25 years of age) 
...... 
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Table 4.8: Odds ratio for risk of isolated gastroschisis according to genitourinary infection in the first trimester of pregnancy, United 
States and Canada, 1998-2010. 
Cases Controls Crude Adjusted* 
N % N % OR 95%CI OR 95%CI 
No STI or UTI 171 72% 6036 85% Reference Reference 
STI or UTI 67 28% 1068 15% 2.22 1.66, 2.96 1.65 1.22, 2.24 
UTI only 33 14% 312 4% 3.73 2.53, 5.51 2.38 1.57, 3.61 
STI only 27 11% 678 10% 1.19 0.96, 1.46 1.09 0.88, 1.36 
STI and UTI 7 3% 78 1% 1.47 1.13, 1.91 1.23 0.93, 1.63 
*Adjusted for maternal age (Referent: 25-29 years of age) 
...... 
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Table 4.9: Sensitivity analysis assessing risk of gastroschisis and GUI in second and third trimester, United States and Canada, 1998-2010. 
2nd trimester 3rd trimester 
Cases N Controls Adjusted 95%CI Cases Controls Adjusted 95%CI (%) N (%} OR* N (%} N (%} OR* 
STI or UTI 21 (8%) 372 (5%) 1.10 0.68, 1.77 14(6%) 379 (5%) 0.78 0.44, 1.37 
UTI only 8 (3%) 149 (2%) 1.01 0.49, 2.06 4 (2%) 125 (2%) 0.55 0.20, 1.55 
STI only 12 (5%) 213 (3%) 1.16 0.64, 2.13 10 (4%) 242 {3%) 0.90 0.46, 1.76 
STI and UTI 1 (0%) 10 (0%) 1.22 0.14, 10.41 0(0%) 12 (0%) 
*Adjusted for maternal age (reference: 25-29 years of age) 
...... 
...... 
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Table 4.10: Odds ratio for the risk of gastroschisis according to genitourinary infection in the first trimester of pregnancy, restricted to 
cases and controls from the same birth hospitals, United States and Canada, 1998-2010. 
Cases Controls Crude Adjusted* 
N % N % OR 95%CI OR 95%CI 
--
NoSTD or UTI 153 69% 2151 85% Ref -- Ref 
STD or UTI 68 31% 369 15% 2.59 1.91, 3.52 2.01 1.43, 2.83 
UTI only 31 14% 111 4% 3.93 2.55, 6.04 2.81 1.72, 4.59 
STD only 30 14% 236 9% 1.34 1.09, 1.64 1.22 0.98, 1.54 
STD and UTI 7 3% 22 1% 1.65 1.23, 2.20 1.41 1.02, 1.95 
* Adjusted for maternal age (Referent: 25-29 years of age) 
1-" 
1-" 
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4.8 FIGURES 
Figure 4.1: Restricted cubic spline for maternal age and gastroschisis, with maternal age model as a continuous (a) and categorical (b) 
variable, United States and Canada, 1998-2010. 
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5 CONCLUSIONS 
Gastroschisis is a puzzling birth defect that, compared to other birth defects, has some 
unusual epidemiologic features. Most notably is that infants of young mothers are 
disproportionally affected by gastroschisis.1' 2 Furthermore, the prevalence of gastroschisis has 
been and continues to increase worldwide.3 There is little evidence to suggest that genetics 
plays a role in the etiology of gastroschisis.1' 4' 5 Despite the increasing number of studies on 
gastroschisis it continues to perplex researchers and therefore the goal ofthis dissertation was 
to explore exposures that could further our understanding of gastroschisis and direct future 
research. 
A couple of hypotheses on the etiology of gastroschisis have been proposed, some of 
which are speculative and need further exploration, while other hypotheses have been 
contradicted with more recent studies. One such hypothesis was that younger women were 
more likely to partake in dangerous behaviors and explained the higher prevalence among 
younger mothers; however, studies that have assessed the relationship between gastroschisis 
and exposures such as smoking and sexually transmitted diseases have not found this to be 
true.6• 7 Another hypothesis put forward was that gastroschisis may be the result of vasoactive 
agents during fetal development. While there is evidence to suggest this,8' 9 there is also 
evidence suggesting that the effect may be restricted to only older women.7 Yet another 
hypothesis suggested that an infectious agent that is more common in younger women and is 
increasing in prevalence could explain the increasing rate of gastroschisis, as well as the 
observed clustering pattern.10 A hypothesis that overlaps with an infectious agent, suggests that 
the immune response is involved in the pathogenesis of gastroschisis.10' 11 
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One clue that may help better understanding the etiology of gastroschisis is the striking 
differences by maternal age. Age itself cannot lead to pathogenic changes as it is just a measure 
of time since birth, but age may be a surrogate for biologic changes that occur with aging or 
even possibly environmental, behavioral or other factors (e.g., nutrition or infections) that may 
be more common in certain age groups. In regards to gastroschisis and maternal age, there are 
two distinguishing characteristics that have been observed. The first is that gastroschisis is more 
prevalent in younger mothers and the second is that when some exposures (e.g., smoking, 
occupational exposures, and paternity changes) have been examined often the association is 
stronger among older women. What could explain a higher prevalence in younger mothers and 
yet also a stronger effect in older mothers? Perhaps different mechanisms are occurring; one 
that might account for the higher prevalence in young mothers, while another mechanism that 
might explain the stronger associations in older mothers. Another possible explanation may be a 
factor, such as an infectious agent, that is more common in younger mothers but due to 
differences in biological responses, older mothers may be more susceptible especially after 
repeated insults from exposures such as cigarette use that would lead to a further weakened 
immune state. We were not able to tease out the specific mechanisms that may be at play, but 
we did see some evidence that infection or environmental factors may play a role in the etiology 
of gastroschisis. 
In study 1, clusters of gastroschisis that occurred in space, as well as the combination of 
space and time, were identified. Using data from the National Birth Defects Prevention Study 
(NBDPS) and registry data the occurrence of clusters were assessed with generalized additive 
models. Maps were created with a continuous surface of odds ratios (ORs) and we found that 
ORs were elevated in multiple study sites even after adjustment for various risk factors. While 
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previous studies have attempted to examine clustering of gastroschisis, this study is the first to 
use rigorous systematic method to quantify clustering of gastroschisis. Based on these results, 
future studies could further explore the areas of increased risk identified to assess if 
environmental or behavioral factors might explain our observations. 
In study 2, temporal clusters of gastroschisis were evaluated using data from the NBDPS. 
Once clusters were identified within each study site, the sociodemographic factors, illnesses and 
behaviors for cases that occurred in a cluster were compared to those that did not occur in a 
cluster. Overall few differences were noted for clustered versus non-clustered cases; however, 
when the data were stratified by maternal age we saw that adjusted ORs were higher among 
older mothers but not younger mothers for the following exposures: alcohol use, heat sources, 
non-steroidal anti-inflammatory drug use, fever, and respiratory illnesses. The observed effect in 
only older women suggest that perhaps the cumulative effect over time for some exposures in 
combination with some aspect of aging (e.g., the immune response) may be responsible for the 
increased risk observed. Future studies could further explore this hypothesis by examining 
markers of immune response and inflammation among clustered and non-clustered mothers. 
In study 3, the association between gastroschisis and genitourinary infections (GUis) was 
examined using data from the Boston University Slone Epidemiology Birth Defects Study (BDS). 
Women who reported GUis had an elevated risk and the highest risk was among women who 
reported urinary tract infections (UTis). The joint effect between young maternal age and UTis, 
suggested an elevated risk greater than what would be expected by the independent effects of 
young maternal age and UTis alone. While a modest increase in risk was observed among older 
mothers, the highest risk was often among younger mothers when the data were stratified by 
maternal age. The various types of treatment reported and the multiple possible underlying 
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pathogens that may have been responsible suggested that there was not one specific infectious 
agent or medication involved. One possibility is that perhaps the inflammatory response itself 
may have been involved, adding further evidence to the hypothesis that infection may be 
involved in the pathogenesis of gastroschisis. 
In all three of these studies there were some reoccurring methodological issues that we 
encountered. The first pertained to exposure and confounder misclassification. In all three 
studies the exposure and confounder information came from maternal reports, either from an 
interview or from what a mother reported on her infant's birth certificate. We cannot rule out 
the possibility that a mother may have misreported her exposure or the timing of her exposure. 
Selection bias was also of concern in all three of our studies. Data that came from NBDPS or BDS 
relied on maternal participation and it is possible that mothers who participated may have been 
different than those who did not. In NBDPS the participation rate for mothers of gastroschisis 
cases is a bit lower than cases overall (64% versus 69%, respectively). This difference could be 
due to case mothers being younger and it has been shown that younger mothers are less likely 
to participate. 12' 13 There was less of a concern for selection bias in the first study where we used 
registry data for Massachusetts and Texas, as all cases ascertained by the registry and a random 
sample of controls were used. Confounding and possible residual confounding was of concern in 
all our studies. Even though we made every attempt to control for as many possible 
confounders, we cannot rule out the possibility of residual confounding. 
Another issue that we encountered in all three studies was how to interpret our results. 
Some studies had small numbers, which led to wide confidence intervals or estimates that did 
not reach statistical significance. While we were hesitant to rely on statistical significance alone, 
we did use it to help us interpret our data, as seen in study 1. In study 2, we had a similar 
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problem with small numbers and when comparing estimates for various risk factors the wide 
confidence intervals often times overlapped, therefore we tried to focus on the elevated risks 
but acknowledge the limitations of having small numbers. 
From a public health perspective, the rising prevalence of gastroschisis is of great 
concern, as is the fact that it disproportionately affects infants of younger mothers. Given that 
little is actually known about the etiology of gastroschisis, more research is needed to explore 
novel exposures and help direct future research. Our goal was to explore possible hypotheses 
that have been suggested as well as generate new directions for future research. The results 
from our studies suggest that infection may be involved in the developmental origins of 
gastroschisis, adding further evidence to the infection hypothesis proposed in the literature. Our 
findings also suggest that environmental or behavioral risk factors may be involved and further 
research in these areas may be fru itful in understanding the etiology of gastroschisis. 
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